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A B S T R A C T
Background
Patellofemoral pain syndrome (PFPS) is a painful musculoskeletal condition, which is characterised by knee pain located in the anterior
aspect (front) and retropatellar region (behind) of the knee joint. Various non-operative interventions are suggested for the treatment
of this condition. Knee orthoses (knee braces, sleeves, straps or bandages) are worn over the knee and are thought to help reduce knee
pain. They can be used in isolation or in addition to other treatments such as exercise or non-steroidal anti-inflammatory medications.
Objectives
To assess the effects (benefits and harms) of knee orthoses (knee braces, sleeves, straps or bandages) for treating PFPS.
Search methods
We searched the Cochrane Bone, Joint and Muscle Trauma Group Specialised Register (11 May 2015), the Cochrane Central Register
of Controlled Trials (CENTRAL) (The Cochrane Library 2015 Issue 5), MEDLINE (1946 to 8 May 2015), EMBASE (1980 to 2015
Week 18), SPORTDiscus (1985 to 11 May 2015), AMED (1985 to 8 May 2015), CINAHL (1937 to 11 May 2015), PEDro (1929
to June 2015), trial registries and conference proceedings.
Selection criteria
Randomised and quasi-randomised controlled clinical trials evaluating knee orthoses for treating people with PFPS. Our primary
outcomes were pain and function.
Data collection and analysis
Two review authors independently assessed studies for eligibility, assessed study risk of bias and extracted data. We calculated mean
differences (MD) or, where pooling data from different scales, standardised mean differences (SMD) with 95% confidence intervals
(CI) for continuous outcomes and risk ratios (RR) with 95% CIs for binary outcomes. We pooled data using the fixed-effect model.
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Main results
We included five trials (one of which was quasi-randomised) that reported results for 368 people who had PFPS. Participants were
recruited from health clinics in three trials and were military recruits undergoing training in the other two trials. Although no trials
recruited participants who were categorised as elite or professional athletes, military training does comprise intensive exercise regimens.
All five trials were at high risk of bias, including performance bias reflecting the logistical problems in these trials of blinding of
participants and care providers. As assessed using the GRADE approach, the available evidence for all reported outcomes is ’very low’
quality. This means that we are very uncertain about the results.
The trials covered three different types of comparison: knee orthosis and exercises versus exercises alone; one type of orthosis versus
another; and knee orthosis versus exercises. No trials assessed the mode of knee orthosis use, such as whether the orthosis was worn all
day or only during physical activity. Two trials had two groups; two trials had three groups; and one trial had four groups.
All five trials compared a knee orthosis (knee sleeve, knee brace, or patellar strap) versus a ’no treatment’ control group, with all
participants receiving exercises, either through a military training programme or a home-based exercise programme. There is very low
quality evidence of no clinically important differences between the two groups in short-term (2 to 12 weeks follow-up) knee pain based
on the visual analogue scale (0 to 10 points; higher scores mean worse pain): MD -0.46 favouring knee orthoses, 95% CI -1.16 to 0.24;
P = 0.19; 234 participants, 3 trials). A similar lack of clinically important difference was found for knee function (183 participants,
2 trials). None of the trials reported on quality of life measures, resource use or participant satisfaction. Although two trials reported
on the impact on sporting or occupational participation, one trial (35 participants) did not provide data split by treatment group on
the resumption of sport activity and the other reported only on abandonment of military training due to knee pain (both cases were
allocated a knee orthosis). One trial (59 participants, 84 affected knees) recording only adverse events in the two knee orthoses (both
were knee sleeves) groups, reported 16 knees (36% of 44 knees) had discomfort or skin abrasion.
Three trials provided very low quality evidence on single comparisons of different types of knee orthoses: a knee brace versus a knee
sleeve (63 participants), a patella strap with a knee sleeve (31 participants), and a knee sleeve with a patellar ring versus a knee sleeve
only (44 knees). None of three trials found an important difference between the two types of knee orthosis in pain. One trial found no
clinically important difference in function between a knee brace and a knee sleeve. None of the three trials reported on quality of life,
resource use or participant satisfaction. One trial comparing a patella strap with a knee sleeve reported that both participants quitting
military training due to knee pain were allocated a knee sleeve. One poorly reported trial found three times as many knees with adverse
effects (discomfort or skin abrasion) in those given knee sleeves with a patella ring than those given knee sleeves only.
One trial compared a knee orthosis (knee brace) with exercise (66 participants). It found very low quality evidence of no clinically
important difference between the two intervention groups in pain or knee function. The trial did not report on quality of life, impact
on sporting or occupational participation, resource use, participant satisfaction or complications.
Authors’ conclusions
Overall, this review has found a lack of evidence to inform on the use of knee orthoses for treating PFPS. There is, however, very low
quality evidence from clinically heterogeneous trials using different types of knee orthoses (knee brace, sleeve and strap) that using
a knee orthosis did not reduce knee pain or improve knee function in the short term (under three months) in adults who were also
undergoing an exercise programme for treating PFPS. This points to the need for good-quality clinically-relevant research to inform
on the use of commonly-available knee orthoses for treating PFPS.
P L A I N L A N G U A G E S U M M A R Y
Knee braces, sleeves or straps for treating anterior knee pain (patellofemoral pain syndrome)
Background
Patellofemoral pain syndrome (PFPS) is a painful knee condition that frequently affects young, physically active people. It is characterised
by pain either to the front of the knee or behind the patella (knee cap). It is suggested that this may be caused by faulty alignment of
the knee cap during knee movements. To help, some physiotherapists provide or people may purchase knee braces, sleeves or straps
(termed ’orthoses’) believed to correct this faulty alignment.
Review question
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We wanted to find out whether wearing knee orthoses in people with anterior knee pain reduces knee pain, improves knee function
and increases the ability to do everyday activities and sports. We also wanted to find out whether there are adverse effects, such as skin
problems, associated with using a knee orthosis. We also wanted to find out what is the best type of knee orthosis and whether wearing
a knee orthosis is better than other types of intervention such as exercise.
Study characteristics
We searched electronic databases and other sources up to June 2015 and found five relevant studies that reported the results for 368
adults with PFPS. Participants were recruited from health clinics in three studies and were military trainees in the other two studies.
All five studies were small and at high risk of bias, which means that their findings may not be reliable.
The studies covered three different types of comparison: knee orthosis and exercises versus exercises alone; one type of orthosis versus
another; and knee orthosis versus exercises. No study assessed the mode of knee orthosis use, such as whether the orthosis was worn all
day or only during physical activity.
Key results
All five trials compared a knee orthosis (either sleeve, brace or strap) plus exercise versus exercise alone. These provided very low quality
evidence that wearing a knee orthosis made no difference to knee pain (data from three studies) and function (data from two studies).
None of the three studies reported on quality of life, resource use or participant satisfaction. One study reported that both participants
quitting military training due to knee pain were allocated a knee orthosis. One poorly reported study found over a third of knees had
discomfort or skin abrasion in those given a knee sleeve.
Three studies provided very low quality evidence on single comparisons of different types of knee orthoses: a knee brace versus a knee
sleeve (63 participants), a patella strap with a knee sleeve (31 participants), and a knee sleeve with a patellar ring versus a knee sleeve
only (44 knees). None of three studies found an important difference between the two types of knee orthosis in knee pain. One study
found no important difference in function between a knee brace and a knee sleeve. None of the three studies reported on quality of
life, resource use or participant satisfaction. One study comparing a patella strap with a knee sleeve reported that both participants
quitting military training due to knee pain were allocated a knee sleeve. One poorly reported study found three times as many knees
with discomfort or skin abrasion in those given knee sleeves with a patella ring than those given knee sleeves only.
One study (66 participants) compared a knee orthosis (knee brace) with exercise. It provided very low quality evidence of no clinically
important difference between the two intervention groups in pain or knee function. It did not report on other outcomes including
complications.
Conclusion
Overall, we found a lack of evidence to inform on the use of knee orthoses for treating PFPS. Our review found very low quality
evidence from trials testing different knee orthoses (knee brace, sleeve and strap) that using a knee orthosis may not reduce knee pain or
improve knee function in the short term (under three months) in adults who were also undergoing an exercise programme for treating
PFPS. These findings point to the need for good-quality clinically-relevant research to inform on the use of commonly-available knee
orthoses for treating PFPS.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Knee orthosis and exercise versus exercise alone for patellofemoral pain syndrome (PFPS)
Patient or population: Adults (recruited from health clinics or military recruits) with PFPS (duration of symptoms ranged from acute, under 2 to 3 weeks in two trials, to predominantly
chronic in three trials: mean durations 8.3 months, 21 months, 21 months)
Settings: Health clinics, home and military training establishments
Intervention: Knee orthosis (various types: knee sleeve, knee brace or patellar strap) and exercise (military training, home exercise programme)
Comparison: Exercise alone
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Exercise alone Knee orthosis and exer-
cise
Pain score (VAS)
Scale from: 0 to 10
(higher scores mean
worse pain)
Follow-up: 3 to 12 weeks
(short-term)
The mean pain score for
the exercise alone group
ranged across the control
groups from 2.7 to 3.2
points; the mean change
score from -0.47 to -0.96
points
The mean pain score in
the knee orthosis and ex-
ercise group was 0.46
points lower (1.16 lower
to 0.24 higher)
MD -0.46 (-1.16 to 0.24) 234 (3) ⊕©©©
very low 1
The MD and 95% CIs do
not include clinically im-
portant treatment effects
MCID: 30 mm on an 100
mm VAS (Lee 2003)
Functional outcomes
Scale various 2
Follow-up:
6 and 12 weeks (short-
term)
The mean functional
score in the knee orthosis
and exercise group was
0.15 points lower (0.69
lower to 0.38 higher)
The mean difference in
knee function (short-
term) in the knee ortho-
sis group was 0.25 stan-
dard deviations lower (0.
55 lower to 0.05 higher)
SMD -0.25 (-0.55 to 0.
05)
183 (2) ⊕©©©
very low 3
Lower values equate to
higher disability.
The SMD result equates
to a small difference at
most and in absolute
terms, the mean differ-
ences for each trial were
small (e.g. 0.9 for a range
0 to 68) and not clinically
important
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Quality of Life and Gen-
eral Health Assessments
See comment See comment No study reported this
outcome
Impact on sporting and
occupational participa-
tion
See comment See comment 51 (1)4 ⊕©©©
very low 5
One trial reported that 2
out of 31 (6.5%) partici-
pants in the knee ortho-
sis groups versus 0 of 20
(0%) in the control group
withdrew from their mili-
tary training programme
Resource use See comment See comment No study reported this
outcome
Participant satisfaction See comment See comment No study reported this
outcome
Complications
Follow-up: 14 weeks6
See comment See comment 59 with 84 affected knees
(1)
⊕©©©
very low 7
Trial reported 16 compli-
cations (skin abrasions or
discomfort) for 44 knees
(36%) of participants in
the knee orthosis group
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence Interval; MCID: Minimal Clinically Important Difference; MD: Mean Difference; RR: Risk Ratio; SMD: Standardised Mean Difference; VAS: Visual Analogue Scale
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1. The quality of the evidence was downgraded two levels for major study limitations resulting in very serious risk of bias (including
selection bias (1 trial) and performance bias (all 3 trials)), and one level for indirectness (this reflects the clinical heterogeneity such
as variation in the interventions and outcome measures and measurement, and the generally inadequate description of these). There
was, however, no statistical heterogeneity in the pooled data.
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2. One trial reported WOMAC functional scores (0 to 68; higher values mean worse function) at six weeks and the other the results of a
modified version of the Knee Function Scale (0 to 53; higher values mean better function) at 12 weeks.
3. The quality of the evidence was downgraded two levels for major study limitations resulting in very serious risk of bias (including
selection bias (1 trial) and performance bias (both trials)), and one level for imprecision (wide confidence intervals and limited data).
4. Data on resumption of sports activities were not split by treatment group in one trial (35 participants).
5. The quality of the evidence was downgraded two levels for major study limitations resulting in very serious risk of bias (including
performance and detection biases), and one level for indirectness (abandonment of military training may be for other reasons than
serious knee pain).
6. The single study recording this outcome did not record complications for all groups. The follow-up for complications appeared be
during use; i.e. the basic military training programme of 14 weeks..
7. The quality of the evidence was downgraded two levels for major study limitations resulting in very serious risk of bias (including
performance and detection biases and serious unit of analyses issues relating to the inclusion of participants with anterior knee pain in
both knees), and imprecision (incomplete data from one small trial).
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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B A C K G R O U N D
Description of the condition
The term ’patellofemoral pain syndrome’ (PFPS) is associatedwith
anterior and retropatellar pain (Grelsamer 2009). This term has
been used interchangeably with other terms, most notably ante-
rior knee pain and patellofemoral syndrome (Grelsamer 2009). It
is more commonly seen in females than in males, and has an esti-
mated prevalence of 12% to 45% amongst young, physically ac-
tive people (Bizzini 2003; Cook 2010; Dixit 2007; Roush 2012).
This wide variation has been attributed to the diversity of people
who may experience this condition; from sedentary adolescents
to military recruits during basic training (Callaghan 2007). PFPS
is characterised by pain behind and around the patella, which is
aggravated during prolonged sitting, descending stairs or slopes,
squatting or kneeling (Dixit 2007; Grelsamer 2009).
The aetiology of PFPS remains unclear (Lankhorst 2012;Waryasz
2008).However, the basic premise is that the patella ’moves’ abnor-
mallywithin the femoral trochlear. This is termedpatellamaltrack-
ing. The patella is most frequently thought to maltrack laterally
and therefore tries to deviate against the lateral femoral trochlear.
Repetitive maltracking is associated with increased sheering and
compressive forces between the retropatellar and femoral trochlear
articulation (Song 2011; Waryasz 2008). The causes of maltrack-
ing are largely acknowledged to bemultifactorial. Factors that may
contribute to this include lateral retinaculum shortening (Hudson
2009), an imbalance between the activation and intensity of vastus
lateralis and vastus medialis muscles (Chester 2008), reduced hip
muscle control (Barton 2013; Cowan 2009), hamstring, quadri-
ceps or calf muscle tightness (Erkula 2002; Waryasz 2008), exces-
sive tibial rotation from foot pronation (Barton 2011), femoral
anteversion (Keser 2008) and trochlear dysplasia (Parikh 2011).
The diagnosis of PFPS is usually derived from a person’s reported
history and their symptoms. A physical examination is impor-
tant to exclude other injuries such as meniscal or ligament tear,
tendinopathy, fracture and dislocation (Dixit 2007). Whilst no
specific criteria exist, typically a person diagnosed with PFPS will
have had symptoms for greater than six weeks, which reflects the
standard research eligibility criteria found in the literature. Phys-
ical examination is also necessary to assess the various different
factors, listed above, which may contribute to the presentation of
PFPS.
Conservative treatment is widely accepted as the primary man-
agement of PFPS (Powers 2012) with one particular high-qual-
ity randomised controlled trial (Van Linschoten 2009) show-
ing that conservative treatment had better outcomes in pain and
function in both the short- and long-term compared to a ’wait
and see’ group. In part reflecting the multifactorial nature of
PFPS, a number of different interventions have been advocated.
These include quadriceps strengthening and stretching exercises
(Chiu 2012), patellar adhesive taping and biofeedback exercises
(Cowan 2002), foot orthotics (Barton 2010), manual therapy
(Brantingham 2012), acupuncture (Jensen 1999) and knee or-
thoses (Bizzini 2003; Powers 2004).
Description of the intervention
This review examined the use of knee orthoses for people with
PFPS. Knee orthoses are essentially external, non-adhesive devices
that aim to modify the position of the patella. The term ’knee
orthosis’ encompasses a variety of different interventions includ-
ing knee braces, sleeves, bandages and straps. They are frequently
made of neoprene and are available in a variety of sizes to account
for different limb circumferences (Shellock 2000). The majority
of orthoses have a ’patella hole’, which is a hole cut out of a neo-
prene sleeve. In addition, in some designs, a strap or buttress is
incorporated into the orthosis. These features are intended to help
maintain the patella in a more central position (Chew 2007).
Knee orthoses have been described as simple, inexpensive and as-
sociated with negligible adverse effects (Warden 2008). People can
purchase orthoses independently, or they may be prescribed by a
healthcare professional. The user can apply the knee orthosis with-
out assistance, which allows them greater control over managing
their knee condition. Knee orthoses can be worn during normal
activities of daily living, as well as during sporting and occupa-
tional pursuits. There is no consensus as to whether bracing should
be used as an adjunct to treatment or on its own for the treatment
of pain for those with PFPS (Dixit 2007).
How the intervention might work
Whilst consensus regarding the aetiology of PFPS is lacking, ab-
normal patellar tracking is largely considered to be the primary
cause (Powers 2004). It has been suggested that knee orthoses work
by centralising the patella within the femoral trochlea, thereby
correcting abnormal patellar tracking and reducing pain (Powers
2004). However, whilst some studies have corroborated that knee
orthoses can alter patellar alignment (Shellock 1994; Shellock
2000), others have reported the contrary during radiological in-
vestigations (Muhle 1999; Powers 1999; Powers 2004).
Knee orthosesmay also have other therapeutic effects. For instance,
wearing the neoprene orthosis may have a thermal effect, which
could increase sensory feedback and proprioception, while also
altering knee circulation (Herrington 2005; Shellock 1995; Van
Tiggelen 2004). Added to this, Earl 2004 reported that knee or-
thoses work by ’unloading’ the patellofemoral joint when orthoses
are used during exercise compared with not wearing a brace. They
postulated that a knee orthosis, by reducing contact forces between
the patella and the femoral trochlea, may reduce the symptoms
related to PFPS. Through this symptomatic relief, it is speculated
that knee orthoses can facilitate greater exercise tolerance and capa-
bility, thus optimising the clinical effects of exercise (Swart 2012).
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Why it is important to do this review
The use of knee orthoses has been widely documented in the lit-
erature for assisting the management of people with PFPS. How-
ever, no systematic reviews have rigorously assessed their applica-
tion for this population. There remains mixed evidence as to the
effectiveness of knee orthoses for this population.
Patellofemoral pain syndrome is acknowledged as a potentially
disabling condition, which can impact on the occupational and
sporting pursuits of children and young adults. Furthermore, pre-
vious authors have acknowledged a potential link between ado-
lescent PFPS and the development of patellofemoral osteoarthri-
tis (Thomas 2010; Utting 2005). The failure of treatment for
PFPS is currently high. Over 90% of people with PFPS continue
to experience pain for more than four years following treatment
(Stathopulu 2003). Given this impact, both in the short- and po-
tentially longer-term, and limited consensus in the effectiveness of
knee orthoses, this review is important to better inform clinicians
and the public on the use of these interventions for treating this
musculoskeletal condition.
O B J E C T I V E S
To assess the effects (benefits and harms) of knee orthoses (knee
braces, sleeves, straps or bandages) for treating PFPS.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials (RCTs) and quasi-ran-
domised (using a method of allocating participants to a treatment
that is not strictly random, e.g. by hospital number) controlled
clinical trials evaluating knee orthoses for treating PFPS. Cross-
over study designswere excluded due to the potential for treatment
’carry-over’ from one randomised arm to another, irrespective of
the duration of the ’wash-out’ period.
Types of participants
We included trials of participants subjectively reporting pain
diagnosed by trial authors as ’patellofemoral pain syndrome’,
’patellofemoral pain’, ’anterior knee pain syndrome’, ’patel-
lar dysfunction’, ’chondromalacia patellae’, ’patellar syndrome’,
’patellofemoral syndrome’ or ’chondropathy’. No restrictions were
placed on the age of the participant, duration of symptoms or stage
of disease as we planned to explore these variables as subgroup
analyses.
Trials where participants were asymptomatic or non-pathologi-
cal were excluded. Trials that recruited participants with a his-
tory of fracture, patellar dislocation, patellar tendinopathy, Hoffa’s
syndrome, Osgood Schlatter syndrome, Sinding-Larsen-Johans-
son syndrome, iliotibial band friction syndrome, osteoarthritis,
rheumatoid arthritis, plica syndromes, or tibiofemoral injury or
dysfunction were also excluded.
Trials reporting the use of orthoses following operative interven-
tions (either immediately post-operatively or at any point follow-
ing surgery) were excluded.
Trials including mixed population studies where a percentage of
the cohort may have some other (possibly undiagnosed) knee
pathology, such as patellar tendinopathy, were excluded unless the
results for the PFPS cohort were presented separately or the num-
bers of such ’undiagnosed’ participants were small and sufficiently
balanced between the intervention groups.
Types of interventions
We included trials evaluating the use of a knee orthosis. A knee
orthosis was defined as a device that aimed to control or change
patellar tracking or loading or both, and could have taken the form
of a knee brace, sleeve, bandage or strap.
Comparisons included:
1. Knee orthosis and non-operative intervention (e.g. exercise)
versus the same non-operative intervention alone.
2. One type of knee orthosis versus another.
3. Knee orthosis versus another non-operative intervention
(e.g. exercise).
4. Mode of knee orthosis use: e.g. length of time worn per
day; whether orthosis is only worn during physical activity versus
all day.
Trials looking at adhesive taping techniques were not included as
they have been assessed in another Cochrane review (Callaghan
2012).
Types of outcome measures
Primary outcomes
1. Pain, e.g. during activity or at rest, measured using a visual
analogue scale (VAS) or similar, preferably at 12 months after
commencing the intervention. Pain could be assessed during a
specific activity (e.g. single leg squat), or more globally, e.g. as
usual pain during the previous week.
2. Functional outcomes, e.g. Western Ontario and McMaster
Universities Index (WOMAC) (Klassbo 2003); Knee Injury and
Osteoarthritis Outcome Score (KOOS) (Roos 1998); Lower
Extremity Functional Scale (LEFS) (Blinkley 1999); Kujala
Patellofemoral Disorder Score/Anterior Knee Pain Scale (Kujala
1993)
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Secondary outcomes
1. Quality of life and general health assessments, e.g. EQ-5D
(EuroQol Group 1990); Short Form-12 (Ware 1996).
2. Impact on sporting or occupational participation, e.g.
duration of occupational sick leave, or time to return to sports at
the same pre-injury level.
3. Resource use/costs of intervention.
4. Participant satisfaction, e.g. Likert scale, VAS or validated
score.
5. Complications of orthoses, e.g. allergies or subsequent
injury.
Biomechanical outcomes such as postural sway, joint propriocep-
tion, force-plate distribution and muscle dynamometry were not
included in this review.
For a study to be included in the review, it had to have measured
one or more of the listed outcomes.
Timing of outcome assessment
For each outcome, the primary end-point for analysis was 12
months. Short-term (zero to three months), medium-term (more
than three months up to 12 months) and long-term (12 months
and over) analyses were also planned in the protocol (Smith 2013).
If there were multiple points within a category, the latest follow-
up period was recorded.
Search methods for identification of studies
Electronic searches
We searched the Cochrane Bone, Joint andMuscle Trauma Group
Specialised Register (11 May 2015), the Cochrane Central Reg-
ister of Controlled Trials (CENTRAL) (The Cochrane Library,
2015 Issue 5), MEDLINE (1946 to May Week 1 2015), MED-
LINE In-Process & Other Non-Indexed Citations (8 May 2015),
MEDLINE Daily Update (8 May 2015), EMBASE (1980 to
2015 Week 18), SPORTDiscus (1985 to 11 May 2015), Al-
lied and Complementary Medicine (AMED) (1985 to 8 May
2015), the Cumulative Index to Nursing and Allied Health Liter-
ature (CINAHL) (1937 to 11May 2015), and the Physiotherapy
Evidence Database (PEDro) (1929 to June 2015). There were no
restrictions on language, date or publication status.
We searched the WHO International Clinical Trials Registry
Platform, the ISRCTN registry, ClinicalTrials.gov and OpenGrey
(System for Information on Grey Literature in Europe) for on-
going or unpublished trials (June 2015). We also searched The
Bone and Joint Journal Orthopaedic Proceedings for conference
proceedings and abstracts (June 2015).
In MEDLINE, a subject-specific search was combined with the
Cochrane Highly Sensitive Search Strategy to identify randomised
trials (sensitivity-maximising version), as described by Lefebvre
2011. Search strategies and associated platforms for all databases
are shown in Appendix 1.
Searching other resources
We scrutinised the reference lists of all pertinent review papers and
eligible trials.
Data collection and analysis
Selection of studies
Two review authors (TS and BD) independently screened the titles
and abstracts of the search strategy results to identity all potentially
eligible trials, for which full-text reports were sought. The same
two authors independently performed study selection. Disagree-
ments in respect to final eligibility were resolved through discus-
sion between the two review authors. The final eligibility of all
papers was adjudicated by a third review author (TM).
Data extraction and management
Two review authors (TM and BD) independently reviewed and
extracted data from each included trial. Disagreements on data ex-
tracted from the original papers were resolved through discussion
between the two review authors. Adjudication by a third review
author (TS) was not required for the data extraction phase.
Assessment of risk of bias in included studies
Two review authors (TM and BD) independently assessed the risk
of bias of the included trials using The Cochrane ’Risk of bias’ tool
(Higgins 2011a). The following domainswere evaluated: sequence
generation, allocation concealment, blinding of participants and
personnel, blinding of outcome assessment, completeness of out-
comedata reporting, selective outcome reporting andother sources
of bias. Since orthoses are visible interventions, worn by partic-
ipants, we acknowledged that it was impossible to blind partici-
pants or personnel to group allocation. However, some blinding
of outcome assessment would still be possible. Any disagreements
were resolved through discussion, adjudicated if necessary by a
third review author (TS), until a consensus was reached.
Measures of treatment effect
We calculated risk ratios (RR) with 95% confidence intervals (CI)
for dichotomous outcomes and mean differences (MD) with 95%
CI for continuous outcomes. For pooling continuous outcome
data where different scales or scores were used, we calculated stan-
dardisedmeandifferences (SMD).To assist interpretation,we used
mean differences for pain visual analogue scales.
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Unit of analysis issues
We included two trials that involved a substantial number of par-
ticipants treated for bilateral symptoms and which reported data
for knees rather than participants.Where possible we reported par-
ticipant data and used the number of participants as denominators
for continuous outcomes to provide a conservative estimate. We
performed sensitivity analyses where possible to explore the effects
on the confidence intervals when using the number of knees as
denominators. We were alert to other potential unit of analysis
issues such as those relating to multiple observations for the same
outcome. Thus, each follow-up period, within the categories de-
fined in Types of outcome measures, was assessed separately to
minimise the risks of unit of analysis errors (Deeks 2011).
Dealing with missing data
We contacted trialists to provide missing data. Unless we could
calculate missing standard deviations from standard errors, exact
P values or 95% confidence intervals, we did not impute these or
any othermissing outcome data. If a paper only provided imputed
data, we emailed the corresponding study author to request the
specific data required on outcomes only from participants who
were assessed. Where possible and appropriate, we used intention-
to-treat analysis results for all review analyses.
Assessment of heterogeneity
We evaluated study heterogeneity from an inspection of the char-
acteristics of the included studies. We assessed statistical hetero-
geneity using Chi² and I² statistics, in addition to visual inspection
of the forest plots (Higgins 2003). We interpreted I² values as rec-
ommended byDeeks 2011. Thus, an I² value of 0% to 40%might
’not be important’; 30% to 60%may represent ’moderate’ hetero-
geneity; 50% to 90% may represent ’substantial’ heterogeneity;
and 75% to 100% represents ’considerable’ heterogeneity.
Assessment of reporting biases
We did not construct a funnel plot to assess possible publication
bias (Sterne 2011) as there were insufficient data.
Data synthesis
When there was heterogeneity between the studies in respect to the
interventions, population or method of assessment, we presented
a narrative review of the results. Otherwise, where possible, we
pooled results of comparable groups of trials using both fixed-effect
and random-effects models. The choice of themodel to report was
guided by a careful consideration of the degree of heterogeneity, as
classified in the Assessment of heterogeneity section, and whether
it could be explained through study design or cohort differences, in
addition to other factors such as the number and size of studies that
were included. We considered not pooling data where there was
considerable heterogeneity (I² > 75%) that could not be explained
by the diversity of methodological or clinical features among the
trials.
To assess treatment effect, we used mean differences to assess con-
tinuous data, whilst risk ratios were used to assess dichotomous
data. We presented 95% CIs throughout. When there was insuffi-
cient data to perform this assessment of treatment effect, or signif-
icant heterogeneity was evident, we presented a narrative review
of the original trial’s findings.
Subgroup analysis and investigation of heterogeneity
Planned subgroup analyses included:
1. Different forms of orthoses: custom-made orthoses;
prefabricated (’off-the-shelf ’) versions; bandages; straps.
2. Age (18 years or over versus under 18 years) and gender.
3. Level of activity (participants who were professional athletes
or in the military forces versus recreational athletes).
There was a lack of data to conduct subgroup analyses for these
parameters.
We considered factors such as age, gender, duration of PFPS symp-
toms prior to randomisation, type of intervention, length of fol-
low-up, level of pre-injury activity and adjusted/unadjusted anal-
yses during the interpretation of heterogeneity.
Sensitivity analysis
We planned to conduct sensitivity analyses to explore different
aspects of trial and review methodology, for example, assessing
outcomes after the exclusion of trials at high risk of selection bias.
However, all included trials were at high risk of various biases and
it was inappropriate to discriminate between these. As all trials
described their population sufficiently, no sensitivity analyses were
performed to see the effect of excluding trials where the population
was poorly defined. There were insufficient data to explore the
effects of missing data, such as studies that presented more than or
equal to 90% of their originally randomised cohort at follow-up,
as recommended by Higgins 2011b. The only sensitivity analyses
performed were to explore the effects of unit of analysis issues
relating the inclusion of participants with bilateral symptoms.
’Summary of findings’ tables
We summarised the results for the main comparison described in
Types of interventions in a ’Summary of findings’ table. For all
comparisons, we used theGRADEapproach to assess the quality of
evidence related to each of the primary outcomes and, if possible,
to at least the first two secondary outcomes listed in Types of
outcome measures (Schünemann 2011).
R E S U L T S
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Description of studies
Results of the search
A summary of the study selection process is shown in Figure 1.
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Figure 1. Study flow diagram
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The search was completed in June 2015. We screened a total
of 3463 records from the following databases: Cochrane Bone,
Joint andMuscle Trauma Group Specialised Register (20 records);
CENTRAL (319), MEDLINE (452), EMBASE (500), AMED
(99), SportDiscus (63), CINAHL (85), the WHO International
Clinical Trials Registry Platform (133), Current Controlled Trials
(42), the PEDro database (1682) and OpenGrey (68). We also
identified 128 potentially eligible trials from a search of the Bone
and Joint Journal’s Orthopaedic Proceedings.
The search identified a total of 33 trials for potential inclusion, for
which, where possible, full reports were obtained.We included five
trials (Evcik 2010; Finestone 1993; Lun 2005;Miller 1997;Moller
1986) and excluded 26 (Antich 1986; Avraham 2007; BenGal
1997; Denton 2005; Draper 2009; Farkas 1997; Fukuschima
1992; Greenwald 1996; Gulling 1996; Lindberg 1988; Lysholm
1984; McCrory 2004; McCrory 2007; Palumbo 1981; Powers
1999; Powers 2004; Roostayi 2009; Sathe 2002; Selfe 2008; Selfe
2011; Straub 2012;Timm1998;VanTiggelen 2004;VanTiggelen
2011; Wijnen 1996; Worrell 1998). Two ongoing studies were
identified (DRKS00003291; IRCT138810293101N1); of these,
one was excluded (IRCT138810293101N1). No studies await
classification.
Included studies
This review included five trials which recruited a total of 391
participants and reported results for 368 of these. Details of the
individual trials are presented in the Characteristics of included
studies.
Design
All five included trials were described as randomised trials but pro-
vided either no or limited information on the method used. Based
on the information supplied, Evcik 2010 appears to be quasi-ran-
domised. Two trials had two groups (Evcik 2010; Moller 1986);
two trials had three groups (Finestone 1993; Miller 1997); and
one trial had four groups (Lun 2005). From the description pro-
vided and the numbers allocated in each group in Finestone 1993,
it is uncertain whether there was randomisation between the two
orthosis groups (see below). The unit of randomisation appeared
to be individual participants in all five trials. Two trials were de-
scribed as single-blinded (Evcik 2010; Lun 2005).
Sample size
The number of participants for whom data were reported in each
trial ranged from 35 (Moller 1986) to 129 (Lun 2005).
Setting
The trialswere performed in one of five different countries: Canada
(Lun 2005), Denmark (Moller 1986), Israel (Finestone 1993),
Turkey (Evcik 2010), andUSA (Miller 1997). All trialswere single-
centre trials.
Participants
Participants in two trials were military recruits undergoing train-
ing (Finestone 1993;Miller 1997). The other three trials recruited
participants from health clinics (Evcik 2010; Lun 2005; Moller
1986). Although no trials recruited participants who were cate-
gorised as elite or professional athletes, military training does com-
prise intensive exercise regimens.
The percentages ofmale participants in the individual trials ranged
from 16% in Evcik 2010 to 100% in Finestone 1993. There were
more females than males in the three non-military trials. Partici-
pant age was not reported in the two military recruit trials. The
mean age of participants was 42 years in Evcik 2010, 35 years in
Lun 2005, and 23 years in Moller 1986.
Two trials recruited participants with bilateral symptoms: 25 par-
ticipants (42%) in Finestone 1993 and 57 participants (44%) in
Lun 2005.
Duration of symptoms varied considerably across the five tri-
als. Symptoms were acute in both two military training trials. In
Finestone 1993, duration of symptoms within two weeks of start-
ing military training and in Miller 1997, within three weeks of
starting military training. The mean duration of symptoms was
8.3 months in Lun 2005 and 21 months in both Evcik 2010 and
Moller 1986. Duration of symptoms ranged from 1 to 80 months
in Evcik 2010 and 3 to 120 months in Moller 1986.
The eligibility criteria for each study are presented in the
Characteristics of included studies tables. The most frequently
used criterion to determine PFPS in trial cohorts was reported
pain on activities such as squatting, prolonged sitting, ascending
or descending stairs, walking or running which was used in four
trials (Evcik 2010; Finestone 1993; Lun 2005; Miller 1997). Posi-
tive signs of symptoms on physical examination including Clarke’s
compression test, apprehension test, maltracking or patellar tilting
were used in two trials (Evcik 2010; Finestone 1993), whilst one
trial included radiological evidence of patellofemoral congruence
(Evcik 2010), and another trial (Moller 1986) based inclusion on
the Turba Score (Turba 1979) for signs and symptoms of PFPS.
Interventions
Three trials tested more than one intervention (Finestone 1993;
Lun 2005; Miller 1997). Consequently, these trials appeared in
more than one comparison in the analyses.
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1. Orthoses
Five different orthoses were used in the included trials. These
were categorised for analysis as either knee braces, knee sleeves or
patellar straps.
Four trials assessed four different knee sleeves (Evcik 2010;
Finestone 1993; Lun 2005;Miller 1997). Evcik 2010 tested a neo-
prene knee sleeve with a patella cut-out (Altex Patellar Knee Sup-
port, AL-2285C). In Finestone 1993, participants received either
an unnamed elastic neoprene knee sleeve without patella cut-out
or a Genutrain knee sleeve with a silicone patellar ring (Bauerfeind
GmbH, Kempen, Germany). In Lun 2005, the knee sleeve group
participants received an unnamed, simple elastic neoprene knee
sleeve, which did not have a patella cut-out. Miller 1997 tested
a neoprene knee sleeve with a patella cut-out and additional sup-
portive straps above and below the patellar (Palumbo Dynamic
Knee Brace - Dynorthotics, Vienna, Virginia).
Two trials assessed knee braces (Lun 2005; Moller 1986). Lun
2005 randomised a group to a Special FX Knee Brace (Generation
II Orthotics Inc, Richmond, British Columbia, USA), which was
a knee brace that included a Y-shaped inferior patellar buttress pad
and external stabilisation strap for the patellofemoral joint. Moller
1986 evaluated the use of a custom-made knee brace made of
orthoplast. This was worn from the mid-thigh region to the foot,
cupping the heel. The brace permitted a knee range ofmotion from
zero to 30degrees of flexion. In comparison, all other knee orthoses
permitted unrestricted knee range of motion. Moller 1986 was the
only study that did not use a pre-fabricated (off-the-shelf ) knee
orthosis.
One study assessed the outcomes of the use of a patella strap
(Miller 1997). This was the Cho-Pat Knee Strap (Cho-Pat Inc,
Hainesport, New Jersey, USA), which was a neoprene buttress
strap that was positioned over the inferior pole of the patella-
superior aspect of the patellar tendon when standing. The orthosis
was purported to reduce patellofemoral joint contact pressures by
off-loading the patellar tendon (Miller 1997).
In two trials, participants randomised to these interventions were
instructed to wear these orthoses throughout the day and during
physical activity, and only to remove them for sleeping or rest pe-
riods (Evcik 2010; Lun 2005). Miller 1997 instructed their par-
ticipants to wear either their knee sleeve or patella strap orthoses
during exercising and all military training activities. Two trials
did not specify when knee orthoses were worn by their partici-
pants (Finestone 1993; Moller 1986). However, Finestone 1993
reported that recruits were not allowed to discontinue their knee
orthoses “without permission of their medical officer”.
The knee orthoses were worn for the duration of the trial’s fol-
low-up periods with the exception of Moller 1986. Moller 1986
required participants to wear the orthosis for six weeks, and eval-
uated outcomes up to 12 months following randomisation.
2. Exercise prescriptions
The exercise prescriptionprovided toparticipants differed between
the included trials. In Finestone 1993, participants were advised
to continue with their basic military training with no additional
therapeutic exercises. In Miller 1997, participants continued on
with their military training but were also enrolled on a physical
therapy programme. The other three trials used a home-based ex-
ercise programme (Evcik 2010; Lun 2005; Moller 1986). All pro-
grammes incorporated basic quadriceps strengthening exercises.
These included isometric and isotonic exercises (Evcik 2010), pro-
gressive squats and lunges (Lun 2005) and targeted vastus medialis
strengthening (Miller 1997). Moller 1986 also included targeted
hamstring strengthening whilst two trials also included stretching
as part of their prescription (Lun 2005; Miller 1997). Full de-
tails of these programmes are presented in the Characteristics of
included studies table.
The duration and intensity of the exercises also varied in their pre-
scription across the trials. This ranged from one set of 10 or more
repetitions five times a week (Evcik 2010), to up to 15 minutes
of exercises four times a day (Moller 1986). Miller 1997 did not
document clearly how many repetitions and how frequently exer-
cises were prescribed and completed.
3. Other co-interventions
Only Miller 1997 acknowledged the inclusion of a second in-
tervention as part of their exercise programme or orthosis pro-
gramme. All participants in this trial were also prescribed 800 mil-
ligrams of ibuprofen, administered three-times daily.
Comparisons
All five trials compared a knee orthosis versus a ’no treatment’
control group, with all participants in the comparison receiving
exercises, either through amilitary training programme (Finestone
1993), a physical therapy programme as well as military training
(Miller 1997), or a home-based exercise programme.
Two trials directly compared different categories of knee orthoses
(Lun 2005; Miller 1997). Lun 2005 compared a knee brace with
a knee sleeve, and Miller 1997 compared a patellar strap with a
knee sleeve. Although one group in Finestone 1993 was given a
knee sleeve with a patellar ring and another group was given a
knee sleeve only, we are unsure whether group allocation to the
two different knee orthoses was randomised.
One trial also compared a knee orthosis (knee brace) with exercise
(Lun 2005).
None of the trials compared different modes of using the same
knee orthosis.
Outcomes
Knee pain was reported by all five trials, with three trials using a
VAS to measure this (Evcik 2010; Lun 2005; Miller 1997). Pain
was assessed on a VAS during sporting activity, one hour after
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sporting activity and following 30 minutes of sitting with knees
flexed in Lun 2005, whilst the change in VAS pain scores from
pre-intervention to final follow-up was assessed in Miller 1997.
A numerical rating of knee pain during activities was used in one
trial (Finestone 1993). In addition, the resolution of pain was
also assessed in Finestone 1993 using a subjectively rated one to
four Likert pain assessment. Moller 1986 assessed swelling, pain,
symptoms of instability, and limitations of activity using criteria
developed by Turba 1979. This involved a numerical rating system
to categorise patient outcomes as excellent, good, fair or poor.
Functional outcomes were assessed in two trials (Evcik 2010; Lun
2005). Evcik 2010 used both the WOMAC score (Klassbo 2003)
and the Fulkerson-Shea Patellofemoral Evaluation score (Owens
2002). Lun 2005 using a modified version of the Knee Function
Scale that had been previously utilised and validated in PFPS (
Werner 1993).
Participant satisfaction with their treatment was assessed in
Finestone 1993 using a one to four Likert system rating. No other
studies specifically assessed patient satisfaction.
The impact on sporting or occupational participationwas reported
in two trials (Miller 1997;Moller 1986).Miller 1997 documented
the number of military personnel (their participants) who con-
tinued their two months of basic military training. Moller 1986
assessed howmany participants returned to sport 12 months post-
randomisation.
The incidence of complications was assessed in one study (
Finestone 1993). This was a planned strategy rather than an ad
hoc assessment of recording complications.
No trials reported data on a number of important outcome mea-
sures including LEFS (Blinkley 1999), the Kujala Patellofemoral
Disorder Score (Kujala 1993) or the KOOS (Roos 1998) scores
for functional outcomes, health-related quality of life or general
health assessments, or data on resource use or costs of the inter-
ventions.
Follow-up periods
Trial follow-up periods for the included trials ranged from six
weeks (Evcik 2010) to 12 months post-randomisation (Moller
1986). Miller 1997 assessed outcomes up to eight weeks, Lun
2005 assessed their participants to 12 weeks, whilst Finestone
1993 assessed outcomes fortnightly over a 14-week basic military
training programme, and then two months following completion
of training.
Data were collected at intervals within these follow-up periods in
four trials (Finestone 1993; Lun 2005;Miller 1997;Moller 1986).
Finestone 1993 assessed their outcomes every two weeks within
their 14-week follow-up period, and two months after comple-
tion of basic military training. Outcomes were assessed at baseline,
three, six and 12 weeks post-randomisation in Lun 2005. The
Miller 1997 cohort were assessed weekly for the duration of their
eight-week follow-up period. Moller 1986 assessed their partici-
pants at six weeks, three months and 12 months post-randomisa-
tion.
Excluded studies
The reasons for not including 27 potentially eligible papers follow-
ing the search strategy results are summarised in theCharacteristics
of excluded studies.
Sixteen studies were excluded because they were neither ran-
domised nor quasi-randomised controlled trials (Draper 2009;
Farkas 1997; Fukuschima 1992; Greenwald 1996; Gulling
1996; IRCT138810293101N1; Lindberg 1988; Lysholm 1984;
McCrory 2004; McCrory 2007; Palumbo 1981; Powers 1999;
Powers 2004; Roostayi 2009; Sathe 2002;Worrell 1998). Two fur-
ther studies were excluded because randomisation was used only
to allocate the order of interventions tested within participants
(Selfe 2011; Straub 2012). Two trials were excluded since they in-
vestigated the use of knee orthoses in the ’prevention’ rather than
’treatment’ of PFPS (BenGal 1997; Van Tiggelen 2004). In three
trials, no form of knee orthosis was investigated (Antich 1986;
Avraham 2007; Wijnen 1996). Two studies were excluded since
they were considered as testing a resistance exercise device rather
than a brace (Denton 2005; Timm 1998). Both studies used a
Protonics exercise device knee brace (Inverse Technology Corpo-
ration, Lincoln, NE) but since the intervention involved a specific
exercise programme, it is predominantly an exercise intervention
rather than a knee orthosis. One trial was excluded since it re-
cruited participants who were without signs or symptoms of PFPS
(Selfe 2008). One trial was excluded since it did not report any of
the pre-defined outcome measures of interest, solely documenting
concentric isokinetic muscle outcomes (Van Tiggelen 2011).
Ongoing studies
Details of the one ongoing trial are provided in the Characteristics
of ongoing studies. DRKS00003291 is a multicentre trial based
in Germany that aims to compare Patella Pro Orthosis plus phys-
iotherapy versus physiotherapy alone in 135 people who have had
PFPS lasting between two months and two years.
Risk of bias in included studies
All five included trials were critically appraised using Cochrane’s
’Risk of bias’ tool (Higgins 2011a). The results for each included
trial are presented in the Characteristics of included studies. A
summary of the risk of bias results is presented graphically in
Figure 2 and Figure 3. All five trials were judged at high risk of bias
from aminimum of three domains, of which one was performance
bias reflecting the logistical problems in these trials of blinding of
participants and care providers.
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Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study
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Allocation
Only Lun 2005 provided adequate details of the method of se-
quence generation (use of a randomnumber generator) and alloca-
tion concealment (independent assignment); based on this infor-
mation, we judged this trial to have a low risk of selection bias. We
judged Evcik 2010 to be a high risk of selection bias reflecting the
quasi-randomisation method of sequence generation, which was
described as being based on “consecutive admissions”. The other
three trials provided no details of their methods and we judged
these at unclear risk of bias for both domains, except for sequence
generation for Finestone 1993. We judged this trial at high risk
of bias because of the lack of clarity on the allocation into one or
other of the two knee-sleeve groups.
Blinding
All five included trials had a high risk of performance bias in re-
spect of blinding of participants and trial personnel. Due to the
nature of knee orthoses and exercise interventions, it may be con-
sidered logistically impossible to blind participants or clinicians
to group allocation. Lun 2005 was the only paper to document
who applied the orthoses under investigation. None of the trials
reported whether any standardised information or ’scripts’ were
used to inform the participants about their orthoses and how and
when to wear them in a standardised way. Accordingly, there was a
high risk of bias from not standardising assessments via this means
and by not blinding clinicians or researchers or both to group al-
location.
Both Evcik 2010 and Lun 2005 claimed to be ’single-blinded’ but
measures to ensure effective blinding to group allocation were not
described. Since subjective outcomes reported by the patients were
not blinded, we judged both trials to be at unclear risk of bias. We
judged the other three trials to be at high risk of detection bias.
Incomplete outcome data
Although all five trials seemed to document the number of par-
ticipants who started and completed the trial, only Evcik 2010
was at low risk of bias relating to incomplete data. Three trials
were at unclear risk of bias, reflecting lack of data on the numbers
of participants, rather than knees, allocated to the interventions
in Finestone 1993, greater than 10% loss to follow-up in Miller
1997, and incomplete reporting of results in Moller 1986. We
judged Lun 2005 at high risk of attrition bias reflecting the post-
randomisation exclusions for which the group allocation was not
reported, and discrepancies between table and figures reporting
pain and function data in the report.
Selective reporting
No trials published a priori protocols. Three trials demonstrated
a high risk of reporting bias within their papers (Finestone 1993;
Miller 1997;Moller 1986), either through not presenting numeri-
cal data to support the conclusions made within the paper (Moller
1986) or not presenting all follow-up interval data for pre-spec-
ified outcome measurements (Finestone 1993; Miller 1997). Of
note, whilst Miller 1997 reported that their cohort was followed
for eight weeks, only the one week, and two to three week data was
presented in the paper. Two trials clearly presented all outcomes
outlined in their methods sections (Evcik 2010; Lun 2005) and
so were judged at unclear risk of bias.
Other potential sources of bias
Three trials were at high risk of other bias (Finestone 1993; Lun
2005; Moller 1986). This reflected unresolvable unit of analyses
issues relating to inclusion of participants with bilateral symptoms
in Finestone 1993 and Lun 2005; and a very poorly described
and probably executed data collection process in Moller 1986.
We judged that the lack of baseline characteristics data for the
individual groups in Miller 1997 put this trial at unclear risk of
other bias.
Effects of interventions
See: Summary of findings for the main comparison Summary
of findings: Knee orthosis (any type) and exercise versus control
(exercise only) for treating patellofemoral pain syndrome
As described, two trials recruited participants with bilateral symp-
toms: 25 participants (42%) in Finestone 1993 and 57 partici-
pants (44%) in Lun 2005. Accordingly there were unit of analy-
sis issues to be considered when conducting our analyses. Addi-
tionally, there were data discrepancies between table and figures in
the article by Lun 2005, a trial that contributes to all three main
comparisons for which there are data. Given the sparse data, no
subgroup analysis was undertaken.
Comparison 1: Knee orthosis and non-operative
intervention (e.g. exercise) versus non-operative
intervention alone
All five included trials compared the use of a knee orthosis and
an exercise programme with an exercise programme alone. Lun
2005 andMoller 1986 assessed knee braces; Evcik 2010, Finestone
1993, Lun 2005 andMiller 1997 assessed knee sleeves; and Miller
1997 also assessed a knee strap. Four trials presented short-term
outcomes (Evcik 2010; Lun 2005; Miller 1997; Moller 1986).
Finestone 1993 presented medium term data with final follow-
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up completed two months after a 14 weeks military training pro-
gramme. One trial presented long-term outcomes at 12 months
(Moller 1986).
Primary outcomes
Pain
Individually, none of the three trials providing pain VAS (0 to 10;
higher scores mean worse pain) data found a significant difference
between knee orthosis versus no knee orthosis at the latest follow-
up for which data were provided (Evcik 2010; Lun 2005; Miller
1997). Pooled final pain score data from Evcik 2010 (knee sleeve)
at sixweeks andLun 2005 (knee brace andknee sleeve) at 12weeks,
and change score data up to two or three weeks for Miller 1997
(knee sleeve and patellar strap) showed no clinically important
or statistically significant difference between knee orthosis plus
exercise versus exercise alone (MD -0.46 favouring knee orthoses,
95% CI -1.16 to 0.24; P = 0.19; 234 participants; Analysis 1.1;
Figure 4). Although the populations and painmeasures and timing
are clinically heterogeneous, the lack of statistical heterogeneity is
notable (Heterogeneity: Chi² = 1.11, df = 4 (P = 0.89); I² = 0%).
A sensitivity analysis using the number of knees as denominators
in Lun 2005 showed a similar result, with the expected narrowing
of the confidence interval ((MD -0.41, 95% CI -1.04 to 0.23;
Analysis 1.2).
Figure 4. Forest plot 1.1. Comparison: knee orthosis and exercises versus exercises alone. Outcome: pain
during activity (0 to 10; higher score means worse pain)
Lun 2005 reported finding no statistically significant differences
between the two groups for either knee orthosis in any of the three
pain assessment scores (0 to 10: higher values mean worse pain)
at 12 weeks post-commencement of treatment. Pooled data from
the two knee orthosis groups for the three pain measures (pain
during sporting activity; pain one hour after sporting activity; pain
following 30 minutes of sitting with knees flexed) are presented
in Analysis 1.3. Also presented are sensitivity analyses using the
number of knees as denominators, which as above display nar-
rower confidence intervals. The pooled results showed no between
group differences in two of the pain measures. Although the re-
sults favoured the control (exercise only) group for pain assessed
one hour after sporting activity, the mean differences were not
clinically important. As noted above, we also have concerns over
data discrepancies in Lun 2005 where the labelling of mean values
presented in the graphs indicated the converse applied.
Finestone 1993 used a subjectively rated four-point Likert pain
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scale (1 (discomfort) to 4 (very severe pain, potentially stopping
training). They reported no statistically significant difference in
pain scores at end of training between participants randomised
to receive a knee sleeve (22 knees; mean score decreased 2.05
points) or a knee sleeve with a patella ring (22 knees; mean score
decreased 1.48 points) and basic military training, compared with
basic military training alone (40 knees; mean score decreased 1.69
points) at 14 weeks post-randomisation (reported P > 0.05).
In Moller 1986, pain was measured as part of the Turba Score,
which was reported at 12 weeks and 12 months follow-up. They
found little difference between the two groups in the numbers of
participants with excellent or good results, reflecting a reduction in
symptoms including swelling, pain and instability and improved
function at either follow-up (Analysis 1.4).
Function
Evcik 2010 reported WOMAC functional scores (0 to 68; higher
values mean worse function) at six weeks and Lun 2005 reported
the results of a modified version of the Knee Function Scale (0 to
53; higher values mean better function). Pooled data from Evcik
2010 (knee sleeve) and Lun 2005 (knee brace and knee sleeve)
favoured the control (exercise only) group (SMD -0.25, 95% CI
-0.55 to 0.05; P = 0.10; Analysis 1.5). A sensitivity analysis using
the number of knees as denominators also favoured the control
group (SMD -0.28, 95% CI -0.55 to -0.01; P = 0.04; Analysis
1.5). The SMD result equates to a small difference at most and in
absolute terms, the mean differences for each trial were small and
not clinically important.
Secondary outcomes
Quality of life
No studies reported this outcome.
Impact on sport/participation
Two trials assessed outcomes on the impact on sport participa-
tion in very different populations (Miller 1997; Moller 1986).
Two participants in the knee orthosis group (both were in the
knee sleeve group) withdrew from the two-month military train-
ing programme (2/31 versus 0/20; RR 3.28, 95% CI 0.17 to
64.99; Analysis 1.6). The data on this outcome were incomplete
forMoller 1986, which reported that 29 of the 35 participants had
given up sports activities at the start and that after three months,
three participants of the knee brace group and two in the con-
trol group had resumed their previous activities. At 12 months,
an overall total of eight participants could perform their previous
activities.
Resource use
No studies reported this outcome.
Participant satisfaction
This outcome was measured but not reported in Finestone 1993.
Complications
Only Finestone 1993 actively recorded complications and in the
knee orthosis groups only. Sixteen complications, consisting of
discomfort or local skin abrasions, were recorded for the 44 knees
in the two knee orthosis groups: 4 (18% of 22 knees) occurred in
the knee sleeve group and 12 (55% of 22 knees) occurred in the
knee sleeve with patellar ring group.
Comparison 2: One type of knee orthosis versus
another
Three trials compared different types of knee orthoses (Finestone
1993; Lun 2005; Miller 1997); all participants in the three trials
also received exercises. However, we are uncertain whether there
was random allocation between the two types of knee orthoses
used in Finestone 1993. Lun 2005 compared a knee brace with
a knee sleeve, Miller 1997 compared a patellar strap with a knee
sleeve, and Finestone 1993 compared knee sleeve with a patellar
(cut-out) ring versus a knee sleeve only.
Primary outcomes
Pain
Three trials reported pain as an outcome (Finestone 1993; Lun
2005; Miller 1997).
Finestone 1993 used a subjectively rated four point Likert pain
scale (1 (discomfort) to 4 (very severe pain, potentially stopping
training). Finestone 1993 reported no statistically significant dif-
ference in pain scores at end of training between participants ran-
domised to receive a knee sleeve (22 knees; mean score decreased
2.05 points) or a knee sleeve with a patella ring (22 knees; mean
score decreased 1.48 points).
Miller 1997 found no difference between a patellar strap versus
a knee sleeve in change of pain scores from pre-intervention to
two to three weeks following the commencement of interventions
(MD 0.26, 95% CI -1.80 to 2.32; 31 participants; Analysis 2.1).
Lun 2005 found no difference between a knee brace versus knee
sleeve in pain during sporting activity scores at 12 weeks (MD -
0.10, 95% CI -1.43 to 1.23; 63 participants; Analysis 2.1). Simi-
lar findings applied to pain assessed following 30 minutes sitting
with knees flexed (data not shown). Lun 2005 found no clinically
important difference between the two orthoses in pain one hour
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after sporting activity scores at 12 weeks (MD 0.70 favouring knee
sleeve, 95% CI -0.46 to 1.86; 63 participants; Analysis 2.1). Sen-
sitivity analysis using the number of knees as denominators also
demonstrated the lack of differences between the two groups, with
narrower confidence intervals.
Function
Only Lun 2005 assessed function as an outcome. Lun 2005 found
no clinically important or statistically significant difference be-
tween the two orthoses in respect to functional outcomes when as-
sessed using the Knee Function Scale (Werner 1993) (MD -1.00,
95% CI -4.95 to 2.95; 63 participants; Analysis 2.2) at 12 weeks
post-commencement of treatment.
Secondary outcomes
Quality of life
No studies reported this outcome.
Impact on sport/participation
Miller 1997 reported the impact on sporting activity. Two par-
ticipants in the knee sleeve group withdrew from the two-month
military training programme (0/13 versus 2/18; RR 0.27, 95%CI
0.01 to 5.22; 31 participants; Analysis 2.3).
Resource use
No studies reported this outcome.
Participant satisfaction
This outcome was measured but not reported in Finestone 1993.
Complications
Finestone 1993 reported 16 complications, consisting of discom-
fort or local skin abrasions, in the two knee sleeve groups (44
knees). Three times as many complication occurred in the knee
sleeve with patellar ring group than in the knee sleeve only group:
12/22 versus 4/22; RR 3.00, 95% CI 1.14 to 7.87; Analysis 2.4).
However, as well as unit of analyses problems (data were presented
by knees only), it is not clear that the two knee orthoses were al-
located randomly.
Comparison 3: Knee orthosis versus another non-
operative intervention (e.g. exercise)
The single trial in this category compared the use of a knee orthosis
versus an exercise programme in 66 participants with PFPS (Lun
2005). Thirty-one participants had bilateral symptoms.
Primary outcomes
Pain
Lun 2005 found no clinically important or statistically significant
differences between the two groups in any of the three pain assess-
ment scores (0 to 10: higher values mean worse pain) at 12 weeks
post-commencement of treatment (66 participants; Analysis 3.1):
pain during sporting activity (MD -0.20 favouring exercise, 95%
CI -1.22 to 0.82), pain one hour after sporting activity (MD 0.40,
95% CI -0.57 to 1.37) and pain following 30 minutes of sitting
with knees flexed (MD 0.40, 95% CI: -0.76 to 1.56). Sensitivity
analyses using the number of knees as denominators also demon-
strated the lack of differences between the two groups, with nar-
rower confidence intervals (Analysis 3.2).
Function
Lun 2005 found no clinically important or statistically significant
differences between the two groups in functional outcome (0 to
53: higher scores mean greater function) at 12 weeks (MD -2.00
favouring exercise, 95%CI -5.88 to 1.88; 66 participants; Analysis
3.3). Sensitivity analyses using the number of knees as denomi-
nators also demonstrated the lack of differences between the two
groups, with narrower confidence intervals (Analysis 3.3).
Secondary outcomes
Lun 2005 did not report on quality of life; impact on sport or
occupational participation, resource use, participant satisfaction
or complications.
Comparison 4: Mode of knee orthosis use
None of the included trials compared clinical outcomes of the
parameters of knee orthosis use such as length of time worn and
whether they were worn only during sporting or occupational
pursuits or all day or night.
D I S C U S S I O N
Summary of main results
This review included five single-centre trials reporting results for
368 adults, who were recruited from routine healthcare settings
(three trials) or military training (two trials). The evidence for all
available outcomes for all comparisons was rated very low quality.
This means that we are very uncertain about the results. The trials
covered three different types of comparison: knee orthosis and
exercises versus exercises alone; one type of orthosis versus another;
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and knee orthosis versus exercises. No trials assessed the mode of
knee orthosis use, such as whether the orthosis was worn all day
or only during physical activity.
All five trials compared a knee orthosis (knee sleeve, knee brace,
or patellar strap) versus a ’no treatment’ control group, with all
participants receiving exercises, either through a military train-
ing programme or a home-based exercise programme. The evi-
dence available for this comparison is summarised in Summary of
findings for the main comparison. This shows there is very low
quality evidence of no clinically important differences between
the two groups in short-term (2 to 12 weeks follow-up) knee pain
(234 participants, 3 trials) or knee function (183 participants (2
trials)). None of the trials reported on quality of life measures such
as the EQ-5D, resource use or participant satisfaction. Although
two trials reported on the impact on sporting or occupational par-
ticipation, one trial (35 participants) did not provide data split
by treatment group on the resumption of sport activity and the
other reported only on abandonment of military training due to
knee pain (both cases were allocated a knee orthosis). One trial
(59 participants, 84 affected knees) recording only adverse events
in the two knee orthoses (both were knee sleeves) groups, reported
16 knees (36% of 44 knees) with discomfort or skin abrasion.
Three trials provided very low quality evidence on single com-
parisons of different types of knee orthosis: a knee brace versus
a knee sleeve (Lun 2005: 63 participants), a patella strap with a
knee sleeve (Miller 1997: 31 participants), and a knee sleeve with a
patellar ring versus a knee sleeve only (Finestone 1993: 44 knees).
None of the three trials found an important difference between
the two types of knee orthosis in pain. Only Lun 2005 reported on
knee function, finding no clinically important difference between
a knee brace and a knee sleeve. None of the trials reported on
quality of life, resource use or participant satisfaction. Miller 1997
reported that both participants quitting military training due to
knee painwere allocated a knee sleeve.While it is not clear whether
Finestone 1993 randomised the allocation of the two knee sleeves,
they found three times as many knees with adverse effects (dis-
comfort or skin abrasion) in those given knee sleeves with a patella
ring than those given knee sleeves only (12/22 versus 4/22).
One trial compared a knee orthosis (knee brace) with exercise
(Lun 2005; 66 participants). It found very low quality evidence of
no clinically important difference between the two intervention
groups in pain or knee function. Lun 2005 did not report on
quality of life, impact on sporting or occupational participation,
resource use, participant satisfaction or complications.
Overall completeness and applicability of
evidence
Despite our comprehensive search, we could include only five
small trials, with a maximum of 45 participants in an intervention
group. Of the 591 recruited participants, we could pool data for
a maximum of 234 (40%) participants for one outcome (pain)
of our main comparison. The data available for other outcomes
and comparisons were evenmore limited. Of particular note is the
lack of data on complications, such as skin abrasions or irritation
for people prescribed knee braces, an outcome reported only in
Finestone 1993.
Below we consider applicability of evidence in terms of the sport
activity, age and gender of the trial participants, the types of knee
orthoses under test, and outcome measurement including timing.
The current evidence has investigated adults in routine healthcare
settings (three trials) or military training (two trials). Although
military recruits would have participated in intensive exercise reg-
imens, no trials specifically recruited participants categorised as
elite or professional athletes. This was a surprising finding given
that previous literature has suggested that PFPS is frequently seen
in this population, most notably those who participate in football,
volleyball and running (Blønd 1998;Myer 2010; Nejati 2011). In
both athletes and military trainees, PFPS is highly prevalent and
can be a major problem resulting in career change (Rauh 2010).
Furthermore, while PFPS is clinically seen in adolescent and child-
hood populations (Bizzini 2003; Cook 2010; Dixit 2007), none
of the included trials focused on this population. This limits the
applicability of these findings to adults only, given the differences
between children and adults in normal everyday activities under-
taken, growth and development factors and potentially compli-
ance with wearing knee orthoses.
The incidence of PFPS is highest in young, physically active fe-
males (Boling 2010). This has been attributed to a difference
in biomechanical features between the genders (Barton 2009;
Nakagawa 2012). It remains unclear whether the biomechanical
effects in modifying patellar tracking that knee orthoses are pur-
ported to offer (Shellock 1994; Shellock 2000) have a different
efficacy between males and females. Moreover, there were insuffi-
cient data from the trials in this review to perform subgroup anal-
yses based on gender.
The current evidence has centred around evaluating the effective-
ness of knee sleeves and knee braces. This is consistent with usage
of these devices and with findings of previous summaries of the
literature (Crossley 2001). Only Miller 1997 investigated clinical
outcomes of a patellar strap, whilst no trials investigated the use
of knee bandages. Overall, there were insufficient data for either
direct or indirect comparisons of the knee orthoses tested by the
included trials to draw conclusions on the relative effects of the
different knee orthoses. Indeed, the statistical homogeneity of the
results for pain is notable given the heterogeneity in the popu-
lations, outcome measurement, including timing, and the knee
orthoses. The descriptions of the application of the knee orthoses
were incomplete, particularly in two trials (Finestone 1993;Moller
1986). Moreover, there is no evidence available to inform on the
optimal parameters for using knee orthoses, e.g. during exercise
only versus during waking hours. Also of note is that an exercise
programme was a co-intervention for the comparisons of knee or-
thoses versus control; no trial compared knee orthosis alone versus
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no knee orthosis.
Although the Kujala Patellofemoral Disorder Score (Kujala 1993)
and WOMAC score (Klassbo 2003) have been shown to be valid
for people with PFPS (Kujala 1993; Laprade 2002), several out-
come measures presented in this review, such as the Turba score
(Turba 1979) and Knee Function Score (Werner 1993), have not
been validated.
The timing of outcome assessment of the included trials also limits
applicability. All but Moller 1986 evaluated outcomes of knee or-
thoses within three months, and so it is unclear whether the results
would differ if the knee orthosis was worn for longer. Where the
same generic outcome was assessed, the trials used different mea-
sures and at different times. This hampers interpretation of the
results and their applicability. Context is also important as illus-
trated by Miller 1997), where our secondary outcome of impact
on sporting or occupational participation, was measured only in
relation to participants discontinuing a basic military training pro-
gramme due to incapacitating anterior knee pain. The relevance
and applicability of this rather blunt outcome to other popula-
tions is very questionable. No trials assessed participant satisfac-
tion, which is important in terms of the expectation of sustained
use of knee orthosis by people with PFPS.
Quality of the evidence
We included five trials (one of which was quasi-randomised) that
reported results for 368 people who had PFPS. All five trials were
at high risk of bias, including performance bias reflecting the lo-
gistical problems in these trials of blinding of participants and care
providers (see Figure 2). As assessed using the GRADE approach,
the available evidence for all reported outcomes is ’very low’ qual-
ity, therefore raising major questions on the reliability of the re-
sults.
The rationales for downgrading the evidence by three levels for
individual outcomes for the comparison of knee orthosis and exer-
cise versus exercise alone are provided in the footnotes of Summary
of findings for the main comparison. For the comparisons of dif-
ference knee orthoses and knee orthosis versus exercise, we down-
graded the evidence two levels formajor study limitations resulting
in very serious risk of bias and one level for imprecision reflecting
that the results were from small single trials.
Potential biases in the review process
Efforts were made to limit potential biases during the review pro-
cess. This included the searching of a variety of relevant published
and grey literature/trial registry databases with no language re-
striction to ensure we identified all relevant trials. Secondly, two
review authors independently conducted the trial identification,
data extraction and assessment of risk of bias, adjudicated by a
third review author. Through this, the process of verification of
data was ensured to minimise the risk of misreporting of trial find-
ings. The analysis results were verified by all review authors, in-
cluding a medical statistician (AC). We adopted a purposefully
conservative approach to the use and interpretation of data from
the two trials that presented substantial unit of analysis issues.
Agreements and disagreements with other
studies or reviews
We identified two recent literature reviews that considered the use
of knee orthosis for treating PFPS (Al-Hakim 2012; Swart 2012).
Al-Hakim 2012, which was a narrative review that evaluated the
use of all non-surgical interventions for PFPS, provided brief sum-
maries of the individual findings of no benefit from knee orthoses
reported by two studies included in our review (Finestone 1993;
Miller 1997). Swart 2012, which was a systematic review that
evaluated the use of lower limb orthoses and taping, identified
three trials testing knee orthoses (Denton 2005; Lun 2005; Miller
1997). Of note is that Denton 2005 is excluded in our review
because we consider the intervention tested is essentially a resis-
tive exercise device and not a knee orthosis. Similar to our review,
Swart 2012 concluded that more high quality studies were needed
“to draw definitive conclusions”.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Overall, this review has found a lack of evidence to inform on
the use of knee orthoses for treating PFPS. There is, however,
very lowquality evidence from clinically heterogeneous trials using
different types of knee orthoses (knee brace, sleeve and strap) that
using a knee orthosis did not reduce knee pain or improve knee
function in the short term (under three months) in adults who
were also undergoing an exercise programme for treating PFPS.
There is either no or very limited and very low quality evidence
on the long-term effects of using knee orthoses, on adverse events
aside from the report of discomfort and skin abrasion in a third of
knees from an extensive use of knee sleeves in one trial, on quality
of life, impact on sporting or occupational participation, resource
use or participant satisfaction. There is very limited and very low
quality evidence on the relative effects of different types of knee
orthosis or the effects of knee orthoses compared with other non-
surgical interventions such as exercise. There is no evidence to
inform on the mode and duration of knee orthosis use.
Implications for research
There is a need for good-quality clinically-relevant research to
inform on the routine use of commonly-available knee orthoses
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for treating PFPS in physically active adults and children. In or-
der to optimise research effort and engender the large, prefer-
ably multicentre, randomised trials that are required to inform
practice, these should be preceded by research that aims to iden-
tify priority questions and attain agreement and, where practi-
cal, standardisation regarding diagnostic criteria, including dura-
tion of symptoms, and measurement of outcome. Helpful in this
regard is the recent progress in moving towards a consensus on
the diagnosis and terminology used to define patellofemoral pain
syndrome summarised in the International Patellofemoral Pain
consensus statements published in 2014 (Witvrouw 2014). No-
tably, these recommendations include the adoption of the term
’patellofemoral pain’. Our call for this preliminary research and
consensus echos recommendations in related Cochrane Reviews
evaluating exercise (Van der Heijden 2015) and patella taping
(Callaghan 2012). Obtaining agreement on diagnosis and out-
come assessment should help to engender the initiation and suc-
cessful delivery of the adequately powered, CONSORT-compli-
ant randomised controlled trials and the acceptance and applica-
bility of their findings (Boutron 2008).
Although the identification of priority topics for the treatment
of people with PFPS requires input from others, we suggest that
priority should be given to further randomised trials evaluating
our main comparison: knee orthosis plus exercise versus exercise
alone in people with PFPS. However, we anticipate the com-
pletion and publication of the only ongoing trial we identified,
which compares a knee orthosis plus physiotherapy versus phys-
iotherapy alone, is also likely to contribute important evidence
(DRKS00003291). Consideration should be given to focusing on
populations, such as professional athletes, for whom knee orthoses
are routinely prescribed for extended periods and for whom per-
sistent PFPS is likely to have more serious consequences including
career change. Trials involving children and adolescents should
also be prioritised. Outcomes should be investigated over a longer
period, at minimum 12 months, and include direct and indirect
costs associated with PFPS and the prescription of knee orthoses,
participant satisfaction and return to sporting or occupational pur-
suits.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Evcik 2010
Methods Prospective, single-centre, single-blinded, randomised controlled trial
Participants Based in Turkey. No recruitment/study dates documented.
We assume participants are ’mixed civilian’ but this is not actually stated
86 participants were recruited (72 female, 14 male; mean age 42 years, range 17 to 80
years) diagnosed with patellofemoral pain syndrome by physicians and an orthopaedic
surgeon
Two groups:
Knee sleeve group: n = 41 (female 35, male 6; age 42.2 years (SD 15.3, range 17 to 80)
; mean duration of symptoms 24.2 months (SD 13.6, range 1 to 80))
Control group: n = 45 (female 37, male 8; age 41.0 years (SD 9.3, range 20 to 59);
mean duration of symptoms 18.2 months (SD 13.2, range 1 to 72))
Inclusion criteria: Anterior or retropatellar knee pain when walking up and down stairs,
squatting, kneeling or prolonged sitting for at least 4 weeks were enrolled in this study.
In addition, they should have pain in at least 2 of the following physical tests: patellar
compression test, in which pressure is applied over the patella while the knee is fully
extended, Clarke’s test (physician places his/her hand over the patient’s patella, presses
gently downwards, as the patient contracts the quadriceps muscle and the test is positive
if pain occurs, which indicates patellofemoral joint problems), patellar apprehension test
(the physician should be aware that patients with a history of subluxation or dislocation
of the patella might feel very uncomfortable at this point and try to stop the physician
from completing the test) and palpation of the posterior medial-lateral borders of the
patella. Hypermobility, measurement of Q-angle and patellar tilt test were also applied.
All participants underwent weight-bearing anteroposterior telemetric X-ray evaluation
and tangential knee radiography in 30 and 45 degrees of flexion. Patellar subluxation
(which was demonstrated by measuring the lateral PF angle), subchondral sclerosis and
presence of degenerative changes were determined from these radiographs. All partici-
pants were diagnosed as having PFPS based on history, physical examination, and radi-
ological evaluation
Exclusion criteria: People with tibiofemoral compartment osteoarthritis, knee effusion,
inflammatory joint pathology, infection, previous knee arthroplasty, lower extremity
fracture history and severe cardiovascular diseases were excluded from the study. After
the physical examination, full blood count, erythrocyte sedimentation rate (ESR), C-
reactive protein (CRP) and biochemical markers were evaluated in order to determine
the presence of other systemic inflammatory diseases
Interventions Knee sleeve group: Received the control group’s exercise programme in addition to an
Altex Patellar Knee support (Altex Patellar knee support AL-2285C), which is a neoprene
sleeve with a patella cut-out. This was worn whilst performing the exercises as well as
during the day for the six-week study period. The knee support was only removed at
night for sleeping
Control group: A home-based exercise therapy including a standardised protocol de-
veloped by a physiotherapist. This consisted of isometric and isotonic programmes for
quadriceps muscles, performed five times per week. All participants performed 10 repe-
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Evcik 2010 (Continued)
titions per day for six weeks. All participants provided with an exercise sheet, outlining
the programme
All participants were reviewed at 2-weekly intervals to monitor compliance to allocated
treatment
Outcomes Outcomes assessed at baseline and at 6 weeks post-commencement of the sleeve and
exercise interventions
Outcomes evaluated included:
1. VAS pain score
2. Western Ontario McMaster Osteoarthritis Index (WOMAC) pain and
functional capacity scales
3. Fulkerson-Shea Patellofemoral Evaluation (FSPES) scores
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Consecutive admission to the outpatient
clinic. Materials and Methods (Page 101)
participantswere “randomly allocated to ei-
ther” group, with “randomisation made ac-
cording to the consecutive admissions of
the patients to the outpatient clinic”
This appears to be quasi-randomised
Allocation concealment (selection bias) High risk Not documented whether allocation was
concealed but this seems unlikely
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No blinding of physiotherapist: Materi-
als and Methods section (page 101): “only
the therapist who applied the therapy was
aware of the therapy”
Although it would be logistically difficult
to blind the participants or study person-
nel to the intervention, the standardisation
of the intervention with the exercise sheet
detailing the home-exercise programme at-
tempted to reduce physiotherapist’s poten-
tial bias
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk The assessor was blinded to group allo-
cation. Methods section (page 101): “the
physicianwas blinded to the treatment pro-
gram”. However, no safeguards were de-
scribed and subjective outcomes reported
by the patients were not blinded
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Evcik 2010 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Results section (page 102): “all patients
completed the regular exercise program”,
therefore none appeared lost to follow-up
Selective reporting (reporting bias) Unclear risk No protocol available. However, all out-
comes presented within the Results section
(page 103) and Table 2, as previously dis-
cussed in the Methods section
Other bias Low risk No other potential bias identified
Finestone 1993
Methods Prospective, single-centre, non-blinded, randomised controlled trial
Participants Based in Israel. Participants recruited in the summer of 1990
All participants were male Israeli army recruits and were diagnosed and reviewed by a
team that comprised an army physician and an orthopaedic surgeon. Review took place
every two weeks during 14 weeks of basic military training
59 participants (all males) with 84 affected and eligible knees were recruited
Three groups:
Genutrain knee sleeve group: n = 22 knees (all male, age: not reported, duration not
stated but was up to 2 weeks)
Simple elastic sleeve group: n = 22 knees (all male, age: not reported, duration not
stated but was up to 2 weeks)
Control group: n = 40 knees (all male, age: not reported, duration not stated but was
up to 2 weeks)
No further details of the participants’ characteristics were included in the text
Eligibility criteria:All participants presentedwith both subjective and objective findings
indicative of patellofemoral pain syndrome, but with no history of knee trauma or
symptoms of patellofemoral pain syndrome prior to joining the miliary services.
Interventions Simple elastic sleeve group: Received same basic military training as the control group
in addition to receiving a simple elastic knee sleeve
Genutrain knee sleeve group: Received same basic military training as the control
group in addition to receiving an elastic knee sleeve with silicone plastic ring (Genutrain,
Bauerfeind GmbH, Kempen, Germany)
The paper does not clearly define when and for how long the knee sleeves were worn by
participants in the two knee sleeve groups
Control group: received no treatment but standard 14 weeks of basic military training
Outcomes Outcomes were evaluated every 2 weeks for a total of 14 weeks during basic military
training and then 2 months following the completion of basic military training
The outcomes assessed were:
1. Pain subjectively rated using a 1 to 4 Likert system where: 1 = discomfort, 2 =
moderate pain, 3 = significant pain but continue to train, 4 = severe pain and stop training
2. Participant satisfaction with their brace/treatment was rated on a 1 to 4 Likert
system. The definitions of each criterion were not provided
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Finestone 1993 (Continued)
3. Complications from wearing the interventions were evaluated through questioning
participants about their experiences. Complications such as the sleeve rubbing or skin
abrasions were recorded
Notes The imbalance in the numbers in the treatment groups was not explained. It is possible
that random allocation applied to treatment (knee orthosis) versus no treatment groups
and not the two knee orthosis groups
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Methods not stated, only that the par-
ticipants were randomised. Materials and
Methods (page 209): “Recruits with
overuse patellofemoral pain were divided
randomly into treatment (Groups 1 and 2)
and nontreatment groups (Group 3).”
Note it is not clear whether any randomisa-
tion occurred for allocation of the different
knee sleeves
Allocation concealment (selection bias) Unclear risk No information provided to indicate
whether participant allocation was con-
cealed
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No information provided in the paper re-
garding blinding of participants or study
personnel and clinicians to group alloca-
tion. However, this would have been logis-
tically difficult to achieve due to the nature
of the intervention
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No information was provided in the paper
indicating whether the assessor was blinded
to group allocation during the data collec-
tion phases
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk All participants appear to be accounted for
at end of the trial. However, group alloca-
tion statistics were available only for knees
not participants. See also ’Other bias’
Selective reporting (reporting bias) High risk Noprotocol available. Pain scoreswere only
reported for baseline and at two months af-
ter completion of their basic military train-
ing. No data presented on participant sat-
isfaction
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Finestone 1993 (Continued)
Other bias High risk It was not explicitly stated how many par-
ticipants in each group presented with bi-
lateral knee symptoms. Results (page 209)
: “59 recruits were diagnosed as having an-
terior knee pain in 84 affected knees”. Un-
resolvable unit of analyses problems
Lun 2005
Methods Prospective, single-centre, single-blinded, randomised controlled trial
Participants Based in Canada. No recruitment/study dates documented.
We assume participants are ’mixed civilian’ but the details of actual composition of
population are not given. The population was drawn from an university sports centre,
university campus community and city fitness facilities, and family physician clientele
152 participants met the inclusion criteria 21 withdrew and 2 crossed over. Data were
reported for 129 participants (76 females, 53 males) with 186 affected knees: diagnosed
and eligibility determined by two sport medicine physicians
Four groups:
Knee brace group: n = 32 (gender not specified; mean age 34 years (SD 11); symptom
duration 8 months (SD 6 months)); 47 knees
Exercise group: n = 34 (gender not specified; mean age 35 years (SD 11); symptom
duration 11 months (SD 8 months)); 50 knees
Exercise and knee brace group: n = 32 (gender not specified; mean age 35 years (SD
11); symptom duration 10 months (SD 7 months)); 45 knees
Exercise and knee sleeve group: n = 31 (gender not specified; mean age 35 years (SD
9); symptom duration 7 months (SD 5 months)); 44 knees
Eligibility criteria: listed under 3 categories in the trial report.
History
• Atraumatic unilateral and/or bilateral peripatellar or retropatellar knee pain for at
least three weeks but not greater than two years
• Patellofemoral knee pain with and/or after activity
• Inactivity patellofemoral pain and/or stiffness, especially with sitting with knees in
a
exed position
• No prior history of any significant knee injury (including but not limited to
patellar subluxations/dislocations/fractures and ligament or meniscal injuries, and so
forth) or knee surgery
• No previous treatment with physiotherapy
Physical examination
• No or minimal articular or soft-tissue periarticular effusion or bursitis
• No significant joint line tenderness
• No intra-articular ligamentous instability
• Peripatellar tenderness
• Mild inferior patellar pole tenderness
X-ray examination
• Participants with any bony abnormalities including bony fracture, osteochondritis
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Lun 2005 (Continued)
dissecans, bipartite patella, or osteoarthritis were excluded from participating in the
study
• Mild inferior patellar pole spurring was acceptable
Interventions Knee brace group: Participants wore a knee brace only. The brace was a Special FX Knee
Brace (Generation II Orthotics, Inc, Richmond, BC). It has a Y-shaped inferior patellar
buttress pad and an external stabilisation strap to help control patellar movement
Exercise group: Participants received a structured home rehabilitation programme only.
This structured home-rehabilitation programme consisted of a strengthening compo-
nent, consisting of a 6-stage progression of 2-leg eccentric drop squats, then single leg
lunges, and finally 1-leg eccentric drop squats. The stretching component of the reha-
bilitation programme consisted of seated spinal rotations, supine hip external rotation,
standing quadriceps stretch, and sitting hamstring stretch. Stretches were performed
daily prior to and after the strengthening component of the programme. Each stretch
was performed passively 3 times, with each stretch held for 30 seconds
Exercise and knee brace group: Participants received the exercise group’s structured
home-rehabilitation and were prescribed and fitted with the Special FX Knee Brace
(Generation II Orthotics, Inc, Richmond, BC) as described above
Exercise and knee sleeve group: Participants received the exercise group’s structured
home-rehabilitation programme and were prescribed and fitted with a knee sleeve con-
structed with same sleeve material as the patella brace. No hole was made in the sleeve
over the patella
The knee braces and knee sleeves were fitted by the second research assistant. In those
diagnosed with bilateral PFPS, both knees were fitted with a knee brace or knee sleeve.
Participants in the brace group, exercise and brace group or exercise and knee sleeve
group were encouraged to wear their braces or sleeves at all times except whilst sleeping
Outcomes The outcome measurements were performed at baseline and at 3, 6 and 12 weeks
Outcomes evaluated were:
1. VAS knee pain rating. This was evaluated in three different situations: during sport
activity; 1 hour after sport activity; and following 30 minutes of sitting with knees
exed
2. Knee Function Scale. For the purpose of this study, the scale was modified. A ’no
pain’ response was added to the occurrence of pain category, with a corresponding score
of 18. The maximum score of the knee function scale was therefore increased to 53,
which equated to normal function
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participants were randomised to interven-
tions. Methods, Study Procedure (page
236): “random number generator with
block design”
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Lun 2005 (Continued)
Allocation concealment (selection bias) Low risk Randomisation was through concealed
allocation through a second researcher.
Methods, Study Procedure (Page 236): “a
second research assistant used a random
number generator with block design to as-
sign subjects to 1 of 4 treatment group.”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No information provided regarding the
blinding of researchers or clinical person-
nel. No information provided regarding
the blinding of study participants; however,
participants or clinician blinding would be
logistically difficult due to the nature of the
study interventions
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Study was described as ’single-blinded’ in
the abstract of the trial report, which also
stated “The investigators were blinded to
the treatment group of each subject.”How-
ever, no information was provided in the
text of the trial report including measures
taken to avoid unblinding of group allo-
cation. Moreover, subjective outcomes re-
ported by the patients were not blinded
Incomplete outcome data (attrition bias)
All outcomes
High risk Separate participant flow not provided for
individual groups. Thus group allocation
of the 21 withdrawals and 2 cross-overs ex-
cluded from the analyses. See also ’Other
bias’
Data inconsistencies andpotential labelling
errors between table 3 and figures in the
article
Selective reporting (reporting bias) Unclear risk No protocol available. However, all out-
comes reported in the Methods section
were reported in the Results section (pages
237 to 239)
Other bias High risk In the Analysis (p 237) it is stated that “If a
subject had bilateral symptoms, each knee
was individually included in the analysis.”
Unresolvable unit of analysis issues
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Miller 1997
Methods Prospective, single-centre, non-blinded, randomised controlled trial
Participants Based in USA. No recruitment/study dates documented.
59 participants (data for 51: 13 females, 38 males). All participants were military cadets.
Unclear who diagnosed and determined eligibility
Three groups:
Palumbo sleeve group: n = 18 (3 female, 15 male; age not reported; duration of symp-
toms within 3 weeks of starting training)
Cho-Pat knee strap group: n = 13 (2 female, 11 male; age not reported; duration of
symptoms within 3 weeks of starting training)
Control group: n = 20 (8 female, 12 male; age not reported; duration of symptoms
within 3 weeks of starting training)
No further information on baseline characteristics available
Inclusion criteria: Complaint of anterior knee pain within first three weeks of military
training
Exclusion criteria: Lack of desire to remain in basic training; previous surgery; history
patellar dislocation; previously known knee disorders; abnormalities on physical exami-
nation; abnormal radiographs
Interventions Palumbo sleeve group: Participants received all interventions provided in the control
group in addition to the provision, fitting and instruction to wear the Palumbo Brace
throughout all military training activities
Cho-Pat knee strap group:Participants received all interventions provided in the control
group in addition to the provision, fitting and instruction to wear the Cho-Pat Knee
Strap throughout all military training activities
’Brace wear was monitored throughout the study to ensure compliance.“ (p11 of article)
Control group: Enrolled in physical therapy consisting of an exercise programme
of closed-chain quadriceps strengthening exercises and a lower limb tissue flexibility
(stretching) programme; ibuprofen prescribed (800 milligrams) 3 times daily; and com-
pletion of basic military physical training
The trainees were allowed to substantially modify their activities at the risk of being
’disenrolled’ from their 2 months training
Outcomes Participants were evaluated weekly from baseline to 8 weeks post-randomisation
The main outcome assessed was the Patient Pain Profile Questionnaire, which incor-
porates a VAS score, a measure of participant’s desire to remain in training and a measure
of their desire to remain in training if their knee pain resolves
Notes The total number of recruits able to complete the training was also documented and the
relevant reasons for attrition explained
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of sequence generation not clearly
documented. Materials andMethods (page
11): participants “were then randomised
into the groups”
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Miller 1997 (Continued)
Allocation concealment (selection bias) Unclear risk No clear documentation as to whether
randomisation was performed through a
concealed method. Materials and Meth-
ods (page 11): participants “were then ran-
domised into the groups”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No information was provided regarding
whether participants or study personnel/
clinicians were blinded to group alloca-
tion. Due to the nature of the intervention,
it would have been logistically difficult to
blind participants to the bracing interven-
tions
Blinding of outcome assessment (detection
bias)
All outcomes
High risk The paper did not detail whether assessors
were blinded to group allocation
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Participant attrition was documented with
all participants accounted for. Materials
and methods page 12: ”four participants
were excluded from the study due to insuf-
ficient follow-up. Four additional patients
failed to complete basic training leaving 51
patients in the study cohort“. While the %
losses were similar in the three groups (13%
to 14%), some bias could result from dif-
fering reasons for missing data
Selective reporting (reporting bias) High risk The Materials and Methods section states
a number of outcome measurements were
collected (Page 11). These included: ”thigh
circumference, effusion, popliteal angle,
compression test, localised tenderness, ap-
prehension test, Q-Angle, range of motion,
Lachmann test, anterior drawer, varus/
valgus instability and McMurray’s tests.”
However, these were not reported
The paper also only reported findings from
the initial 3-week follow-up period, ne-
glecting to provide data from weeks 4 to 8.
No explanation was provided for this dis-
crepancy in reporting
Other bias Unclear risk Baseline characteristics not provided for all
randomised participants
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Moller 1986
Methods Prospective, single-centre, non-blinded, randomised controlled trial
Participants Based in Denmark. No recruitment/study dates documented
We assume participants are ’mixed civilian’ but this is not actually stated. Unclear who
diagnosed and determined eligibility
35 participants (35 unilateral knees) (25 female, 10 male; mean age 23 years (range 18
to 35); mean duration of symptoms 21 months (3 to 120 months))
Two groups:
Knee brace group: n = 17 (gender, age and duration of symptoms not specified; 10
participants had a history of patellar subluxation and 7 participants had a history of
idiopathic chondromalacia patellae)
Control group: n = 18 (gender, age and duration of symptoms not specified; 7 partici-
pants had a history of patellar subluxation; and 11 participants had a history of idiopathic
chondromalacia patellae)
Inclusion criteria: Arthroscopy was done on all knees and revealed different stages of
diseased articular cartilage. The knees were initially evaluated subjectively and objectively
according to the numerical rating system described by Turba 1979, assessing swelling,
pain, symptoms of instability, and limitation of activity. Objectively, the evaluation
included motion, pain effusion, quadriceps atrophy, and patellar hypermobility
Exclusion criteria:Patients with obvious signs of meniscus tears, joint laxity, radiological
osteoarthritis, former surgery of the knee, or recurrent subluxation of the patella
Interventions Knee brace group: In addition to the exercise programme, participants in this group
wore a knee brace made of orthoplast. The brace only allowed a knee range of motion
from 0 to 30 degrees of flexion. The brace was worn for a 6-week period. No details
provided with regards to whether the brace was worn at night or not
Control group: An isometric quadriceps and hamstrings exercise programme. This was
performed for at least 15minutes, 4 times daily. Participants were asked to exercise within
the limits of their pain
Outcomes A follow-up was performed after 6 weeks and 3 and 12 months
Outcome measures included:
1. TheTurba 1979rating system. This is a numerical rating outcome measure to
assess the extensor mechanism of the knee in respect to swelling, pain, symptoms of
instability, and limitation of activity. Results were categorised as excellent, good, fair,
and poor. The knees were rated as improved only if the results were excellent or good
both objectively and subjectively
2. Mean quadriceps circumference
3. Likert scale based on subjective improvement
4. Return to activity
Notes Five participants subsequently underwent surgery; 4 for correction of patellar malalign-
ment
Risk of bias
Bias Authors’ judgement Support for judgement
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Moller 1986 (Continued)
Random sequence generation (selection
bias)
Unclear risk No mention of randomisation procedure.
No detail provided regarding sequence
generation. Patients and Methods section
(page 377) “seventeen patients were ran-
domised to a knee brace made of ortho-
plast”
Allocation concealment (selection bias) Unclear risk No mention of randomisation procedure,
with the methods of allocation conceal-
ment not described
Blinding of participants and personnel
(performance bias)
All outcomes
High risk This was not described in the paper. It was
unclear from information presented in the
paper which personnel were involved in
the trial and whether they were blinded to
group allocation. Given the nature of this
intervention, it would be logistically diffi-
cult to blind participants or personnel to
group allocation
Blinding of outcome assessment (detection
bias)
All outcomes
High risk There was insufficient information detail-
ing potential assessor blinding, and data
collection of the outcome measures
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk All participants seem to be accounted in the
Results section (page 378) but incomplete
reporting of data (see next item)
Selective reporting (reporting bias) High risk All outcome measures discussed in the Pa-
tients andMethods sections were presented
in the Results section (page 387). However,
no raw data were available and no numeri-
cal values were provided for the Turba scale.
The paper only presented the frequency of
’excellent’ and ’good’ results as a combined
number. It was therefore difficult to inter-
pret the Results (Page 378 and Table 1)
Other bias High risk The Patients and Methods section was not
clear, particularly in relation to the data
collection procedure, which was not de-
scribed.
No separate baseline characteristics (sex,
age, duration of symptoms) provided
Outcomes in bold are those that are relevant for this review.
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Antich 1986 No orthosis examined
Avraham 2007 No orthosis examined
BenGal 1997 Examined the use of orthosis as a ’preventative’ rather than ’treatment’ intervention
Denton 2005 The intervention under investigation was a resistance exercise device rather than a brace or orthosis
Draper 2009 Not a randomised controlled trial
Farkas 1997 Not a randomised controlled trial
Fukuschima 1992 Not a randomised controlled trial
Greenwald 1996 Not a randomised controlled trial
Gulling 1996 Not a randomised controlled trial
IRCT138810293101N1 Not a randomised controlled trial
Lindberg 1988 Not a randomised controlled trial
Lysholm 1984 Not a randomised controlled trial
McCrory 2004 Not a randomised controlled trial
McCrory 2007 Not a randomised controlled trial
Palumbo 1981 Not a randomised controlled trial
Powers 1999 Not a randomised controlled trial
Powers 2004 Not a randomised controlled trial
Roostayi 2009 Not a randomised controlled trial
Sathe 2002 Not a randomised controlled trial
Selfe 2008 None of the participants presented with patellofemoral pain syndrome; all had pain-free knees
Selfe 2011 Randomisation was used to allocate the order of treatment within individual participants but not the
allocation of interventions among participants
Straub 2012 Randomisation was used to allocate the order of treatment within individual participants but not the
allocation of interventions among participants. None of the participants presented with patellofemoral
pain syndrome
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Timm 1998 The intervention under investigation was a resistance exercise device rather than a brace or orthosis
Van Tiggelen 2004 Recruited participants who did not have patellofemoral pain syndrome.Outcomemeasurement of interest
was the ’prevention’ not the ’treatment’ of patellofemoral pain syndrome
Van Tiggelen 2011 Paper solely reported concentric isokinetic test results. This outcome was not a pre-specified outcome
measure of interest in this review
Wijnen 1996 A comparison of two taping techniques with no investigation of orthosis interventions
Worrell 1998 Not a randomised controlled trial
Characteristics of ongoing studies [ordered by study ID]
DRKS00003291
Trial name or title “Therapy of the patellofemoral pain syndrome: A prospective randomised study with two treatment groups:
Physiotherapy and 2. Recentering orthosis plus physiotherapy”
Methods Open, randomised controlled trial
Participants 135 male and females aged between 18 and 50 (target recruitment)
Inclusion criteria: patient’s suffering longer than 2 months but not longer than 2 years with any 3 of the
following symptoms: anterior knee pain while running; anterior knee pain while climbing stairs; anterior knee
pain while bicycling; anterior knee pain while sitting with flexed knees; anterior knee pain while squatting
Exclusion criteria: osteoarthritis 3° to 4°; local cartilage damage 3° to 4°; subluxation of the patella; previous
knee injuries (ACL ruptures); tendinosis of the patella tendon; Osgood Schlatter; pathological damage of the
knee joint (osteochondrosis dissecans); valgus knee with more than 3 fingers between the malleoli; varus knee
with more than 2 fingers between the femoral condyles
Interventions Group 1: prescription of physiotherapy: 12 x 30-minute physiotherapy sessions (to be delivered x 2 weekly
sessions over a 6-week period)
Group 2: a Patella Pro Orthosis and a prescription of physiotherapy (12 x physiotherapy for 30 minutes).
The patients should wear the Patella Pro Orthosis for 6 hours even during physiotherapy
Outcomes 1. A ’healing’ score (7 points Likert scale)
2. The Kujala Patellofemoral Disorder Score
3. The Knee Pain and Osteoarthritis Outcome Score (KOOS)
4. Severity of pain at several activities measured on a numerical analogue scale (0 to 100)
Outcomes will be measured at the initial visit, 6 weeks, 3 months and 12 months
Starting date 01.03.2012
Contact information Wolf Petersen, Caspar Theyys Strasse 27-31, 14193, Berlin, Germany, w.petersen@mlk-berlin.de
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Notes Commercial source of funding: Otto Bock Health Care GmbH Abt. Medical Affairs, Germany
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D A T A A N D A N A L Y S E S
Comparison 1. Knee orthosis and non-operative intervention (exercises) versus non-operative intervention (ex-
ercises) alone
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain during activity (0 to 10;
higher score means worse pain)
3 234 Mean Difference (IV, Fixed, 95% CI) -0.46 [-1.16, 0.24]
1.1 Knee sleeve 3 162 Mean Difference (IV, Fixed, 95% CI) -0.48 [-1.31, 0.35]
1.2 Patellar strap 1 23 Mean Difference (IV, Fixed, 95% CI) -1.09 [-3.71, 1.53]
1.3 Knee brace 1 49 Mean Difference (IV, Fixed, 95% CI) -0.20 [-1.68, 1.28]
2 Pain scores (0 to 10; higher score
means worse pain)
3 Mean Difference (IV, Fixed, 95% CI) Subtotals only
2.1 Knee orthosis (any) 3 234 Mean Difference (IV, Fixed, 95% CI) -0.46 [-1.16, 0.24]
2.2 Sensitivity analysis
(knees). Knee orthosis (any)
3 276 Mean Difference (IV, Fixed, 95% CI) -0.41 [-1.04, 0.23]
3 Different pain scores (0 to 10;
higher score means worse pain)
at 12 weeks
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
3.1 Pain during activity 1 97 Mean Difference (IV, Fixed, 95% CI) -0.15 [-1.20, 0.90]
3.2 Sensitivity analysis
(knees). Pain during activity
1 139 Mean Difference (IV, Fixed, 95% CI) -0.15 [-1.02, 0.72]
3.3 Pain 1 hour after sporting
activity
1 97 Mean Difference (IV, Fixed, 95% CI) 0.75 [-0.19, 1.69]
3.4 Sensitivity analysis
(knees). Pain 1 hour after
sporting activity
1 139 Mean Difference (IV, Fixed, 95% CI) 0.75 [-0.04, 1.53]
3.5 Pain after 30 minutes
sitting with knees flexed
1 97 Mean Difference (IV, Fixed, 95% CI) 0.25 [-0.82, 1.32]
3.6 Sensitivity analysis
(knees). Pain after sitting with
knees flexed
1 139 Mean Difference (IV, Fixed, 95% CI) 0.25 [-0.64, 1.14]
4 Excellent or good results in terms
of reduction in symptoms
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
4.1 At 12 weeks 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.2 At 12 months 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Functional scores (higher score
means higher function)
2 Std. Mean Difference (IV, Fixed, 95% CI) Subtotals only
5.1 Knee orthosis (any) 2 183 Std. Mean Difference (IV, Fixed, 95% CI) -0.25 [-0.55, 0.05]
5.2 Sensitivity analysis
(knees): Knee orthosis (any)
2 225 Std. Mean Difference (IV, Fixed, 95% CI) -0.28 [-0.55, -0.01]
6 Discontinuation of a basic
military training programme
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
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Comparison 2. One type of orthosis versus another type
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain score (0 to 10: higher score
means worse pain)
2 Mean Difference (IV, Fixed, 95% CI) Totals not selected
1.1 Patellar strap versus knee
sleeve
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 Knee brace versus knee
sleeve
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 Knee brace versus knee
sleeve (sensitivity analysis:
knees)
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.4 Knee brace versus knee
sleeve
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.5 Knee brace versus knee
sleeve (sensitivity analysis:
knees)
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Functional score (0 to 53: higher
scores means greater function)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
2.1 Knee brace versus knee
sleeve
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 Knee brace versus knee
sleeve (sensitivity analysis:
knees)
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Discontinuation of a basic
military training programme
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
3.1 Patellar strap versus knee
sleeve
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Complications 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
4.1 Knee sleeve and patella
ring versus knee sleeve without
patellar ring
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
Comparison 3. Orthosis versus exercise
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain during activity (0 to 10:
higher score means worse pain)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
1.1 Pain score during sporting
activity
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 Pain score 1 hour after
sporting activity
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
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1.3 Pain score following 30
minutes of sitting with knees
flexed
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Sensitivity analyses (knees): Pain
during activity (0 to 10: higher
score means worse pain)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
2.1 Pain score during sporting
activity
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 Pain score 1 hour after
sporting activity
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 Pain score following 30
minutes of sitting with knees
flexed
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Functional scores (0 to 53:
higher scores means greater
function)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
3.1 Participants =
denominators
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 Sensitivity analysis (knees) 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
Analysis 1.1. Comparison 1 Knee orthosis and non-operative intervention (exercises) versus non-operative
intervention (exercises) alone, Outcome 1 Pain during activity (0 to 10; higher score means worse pain).
Review: Knee orthoses for treating patellofemoral pain syndrome
Comparison: 1 Knee orthosis and non-operative intervention (exercises) versus non-operative intervention (exercises) alone
Outcome: 1 Pain during activity (0 to 10; higher score means worse pain)
Study or subgroup
Knee
orthosis +
exercise
Control
(exercise
alone)
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Knee sleeve
Evcik 2010 (1) 41 3.2 (2.9) 45 3.7 (2.2) 40.2 % -0.50 [ -1.60, 0.60 ]
Lun 2005 (2) 31 2.8 (2.7) 17 2.9 (2.4) 21.9 % -0.10 [ -1.58, 1.38 ]
Miller 1997 (3) 18 -2.04 (2.65) 10 -0.69 (3.28) 8.6 % -1.35 [ -3.72, 1.02 ]
Subtotal (95% CI) 90 72 70.8 % -0.48 [ -1.31, 0.35 ]
Heterogeneity: Chi2 = 0.77, df = 2 (P = 0.68); I2 =0.0%
Test for overall effect: Z = 1.14 (P = 0.26)
2 Patellar strap
Miller 1997 (4) 13 -1.78 (3.04) 10 -0.69 (3.28) 7.0 % -1.09 [ -3.71, 1.53 ]
Subtotal (95% CI) 13 10 7.0 % -1.09 [ -3.71, 1.53 ]
Heterogeneity: not applicable
-4 -2 0 2 4
Favours knee orthosis Favours control
(Continued . . . )
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(. . . Continued)
Study or subgroup
Knee
orthosis +
exercise
Control
(exercise
alone)
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Test for overall effect: Z = 0.82 (P = 0.41)
3 Knee brace
Lun 2005 (5) 32 2.7 (2.7) 17 2.9 (2.4) 22.2 % -0.20 [ -1.68, 1.28 ]
Subtotal (95% CI) 32 17 22.2 % -0.20 [ -1.68, 1.28 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.27 (P = 0.79)
Total (95% CI) 135 99 100.0 % -0.46 [ -1.16, 0.24 ]
Heterogeneity: Chi2 = 1.11, df = 4 (P = 0.89); I2 =0.0%
Test for overall effect: Z = 1.30 (P = 0.19)
Test for subgroup differences: Chi2 = 0.34, df = 2 (P = 0.84), I2 =0.0%
-4 -2 0 2 4
Favours knee orthosis Favours control
(1) Pain at 6 weeks
(2) Pain at 12 weeks; unit of analysis issue - inclusion of people with bilateral involvement (45% of population)
(3) Change in pain score; pre-treatment to 2 to 3 weeks
(4) Change in pain score; pre-treatment to 2 to 3 weeks
(5) Pain at 12 weeks; unit of analysis issue - inclusion of people with bilateral involvement (44% of population)
47Knee orthoses for treating patellofemoral pain syndrome (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.2. Comparison 1 Knee orthosis and non-operative intervention (exercises) versus non-operative
intervention (exercises) alone, Outcome 2 Pain scores (0 to 10; higher score means worse pain).
Review: Knee orthoses for treating patellofemoral pain syndrome
Comparison: 1 Knee orthosis and non-operative intervention (exercises) versus non-operative intervention (exercises) alone
Outcome: 2 Pain scores (0 to 10; higher score means worse pain)
Study or subgroup
Knee
orthosis +
exercise
Control
(exercise
alone)
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Knee orthosis (any)
Evcik 2010 (1) 41 3.2 (2.9) 45 3.7 (2.2) 40.2 % -0.50 [ -1.60, 0.60 ]
Lun 2005 (2) 31 2.8 (2.7) 17 2.9 (2.4) 21.9 % -0.10 [ -1.58, 1.38 ]
Lun 2005 (3) 32 2.7 (2.7) 17 2.9 (2.4) 22.2 % -0.20 [ -1.68, 1.28 ]
Miller 1997 (4) 13 -1.78 (3.04) 10 -0.69 (3.28) 7.0 % -1.09 [ -3.71, 1.53 ]
Miller 1997 (5) 18 -2.04 (2.65) 10 -0.69 (3.28) 8.6 % -1.35 [ -3.72, 1.02 ]
Subtotal (95% CI) 135 99 100.0 % -0.46 [ -1.16, 0.24 ]
Heterogeneity: Chi2 = 1.11, df = 4 (P = 0.89); I2 =0.0%
Test for overall effect: Z = 1.30 (P = 0.19)
2 Sensitivity analysis (knees). Knee orthosis (any)
Evcik 2010 (6) 41 3.2 (2.9) 45 3.7 (2.2) 33.6 % -0.50 [ -1.60, 0.60 ]
Lun 2005 (7) 44 2.8 (2.7) 25 2.9 (2.4) 26.5 % -0.10 [ -1.33, 1.13 ]
Lun 2005 (8) 45 2.7 (2.7) 25 2.9 (2.4) 26.8 % -0.20 [ -1.43, 1.03 ]
Miller 1997 (9) 13 -2.04 (2.65) 10 -0.69 (3.28) 6.5 % -1.35 [ -3.84, 1.14 ]
Miller 1997 (10) 18 -1.78 (3.04) 10 -0.69 (3.28) 6.6 % -1.09 [ -3.56, 1.38 ]
Subtotal (95% CI) 161 115 100.0 % -0.41 [ -1.04, 0.23 ]
Heterogeneity: Chi2 = 1.22, df = 4 (P = 0.88); I2 =0.0%
Test for overall effect: Z = 1.26 (P = 0.21)
-4 -2 0 2 4
Favours knee orthosis Favours control
(1) Knee brace. Pain at 6 weeks
(2) Knee sleeve. Pain during activity at 12 weeks
(3) Knee brace. Pain during activity at 12 weeks
(4) Patellar strap. Change in pain score; pre-treatment to 2 to 3 weeks
(5) Knee sleeve. Change in pain score; pre-treatment to 2 to 3 weeks
(6) Knee brace. Pain at 6 weeks
(7) Knee sleeve. Pain during activity at 12 weeks
(8) Knee brace. Pain during activity at 12 weeks
(9) Patellar strap. Change in pain score; pre-treatment to 2 to 3 weeks
(10) Knee sleeve. Change in pain score; pre-treatment to 2 to 3 weeks
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Analysis 1.3. Comparison 1 Knee orthosis and non-operative intervention (exercises) versus non-operative
intervention (exercises) alone, Outcome 3 Different pain scores (0 to 10; higher score means worse pain) at 12
weeks.
Review: Knee orthoses for treating patellofemoral pain syndrome
Comparison: 1 Knee orthosis and non-operative intervention (exercises) versus non-operative intervention (exercises) alone
Outcome: 3 Different pain scores (0 to 10; higher score means worse pain) at 12 weeks
Study or subgroup
Knee
orthosis +
exercise
Control
(exercise
alone)
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Pain during activity
Lun 2005 (1) 31 2.8 (2.7) 17 2.9 (2.4) 49.7 % -0.10 [ -1.58, 1.38 ]
Lun 2005 (2) 32 2.7 (2.7) 17 2.9 (2.4) 50.3 % -0.20 [ -1.68, 1.28 ]
Subtotal (95% CI) 63 34 100.0 % -0.15 [ -1.20, 0.90 ]
Heterogeneity: Chi2 = 0.01, df = 1 (P = 0.93); I2 =0.0%
Test for overall effect: Z = 0.28 (P = 0.78)
2 Sensitivity analysis (knees). Pain during activity
Lun 2005 (3) 45 2.7 (2.7) 25 2.9 (2.4) 50.2 % -0.20 [ -1.43, 1.03 ]
Lun 2005 (4) 44 2.8 (2.7) 25 2.9 (2.4) 49.8 % -0.10 [ -1.33, 1.13 ]
Subtotal (95% CI) 89 50 100.0 % -0.15 [ -1.02, 0.72 ]
Heterogeneity: Chi2 = 0.01, df = 1 (P = 0.91); I2 =0.0%
Test for overall effect: Z = 0.34 (P = 0.74)
3 Pain 1 hour after sporting activity
Lun 2005 (5) 32 3.2 (2.4) 17 2.1 (2.2) 49.5 % 1.10 [ -0.24, 2.44 ]
Lun 2005 (6) 31 2.5 (2.3) 17 2.1 (2.2) 50.5 % 0.40 [ -0.92, 1.72 ]
Subtotal (95% CI) 63 34 100.0 % 0.75 [ -0.19, 1.69 ]
Heterogeneity: Chi2 = 0.53, df = 1 (P = 0.47); I2 =0.0%
Test for overall effect: Z = 1.56 (P = 0.12)
4 Sensitivity analysis (knees). Pain 1 hour after sporting activity
Lun 2005 (7) 45 3.2 (2.4) 25 2.1 (2.2) 49.4 % 1.10 [ -0.01, 2.21 ]
Lun 2005 (8) 44 2.5 (2.3) 25 2.1 (2.2) 50.6 % 0.40 [ -0.70, 1.50 ]
Subtotal (95% CI) 89 50 100.0 % 0.75 [ -0.04, 1.53 ]
Heterogeneity: Chi2 = 0.77, df = 1 (P = 0.38); I2 =0.0%
Test for overall effect: Z = 1.87 (P = 0.061)
5 Pain after 30 minutes sitting with knees flexed
Lun 2005 (9) 31 2.8 (2.7) 17 2.5 (2.5) 49.7 % 0.30 [ -1.22, 1.82 ]
-2 -1 0 1 2
Favours knee orthosis Favours control
(Continued . . . )
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(. . . Continued)
Study or subgroup
Knee
orthosis +
exercise
Control
(exercise
alone)
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Lun 2005 (10) 32 2.7 (2.7) 17 2.5 (2.5) 50.3 % 0.20 [ -1.31, 1.71 ]
Subtotal (95% CI) 63 34 100.0 % 0.25 [ -0.82, 1.32 ]
Heterogeneity: Chi2 = 0.01, df = 1 (P = 0.93); I2 =0.0%
Test for overall effect: Z = 0.46 (P = 0.65)
6 Sensitivity analysis (knees). Pain after sitting with knees flexed
Lun 2005 (11) 44 2.8 (2.7) 25 2.5 (2.5) 49.8 % 0.30 [ -0.96, 1.56 ]
Lun 2005 (12) 45 2.7 (2.7) 25 2.5 (2.5) 50.2 % 0.20 [ -1.06, 1.46 ]
Subtotal (95% CI) 89 50 100.0 % 0.25 [ -0.64, 1.14 ]
Heterogeneity: Chi2 = 0.01, df = 1 (P = 0.91); I2 =0.0%
Test for overall effect: Z = 0.55 (P = 0.58)
-2 -1 0 1 2
Favours knee orthosis Favours control
(1) Knee sleeve.
(2) Knee brace.
(3) Knee brace.
(4) Knee sleeve.
(5) Knee brace
(6) Knee sleeve
(7) Knee brace.
(8) Knee sleeve.
(9) Knee sleeve
(10) Knee brace
(11) Knee sleeve
(12) Knee brace
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Analysis 1.4. Comparison 1 Knee orthosis and non-operative intervention (exercises) versus non-operative
intervention (exercises) alone, Outcome 4 Excellent or good results in terms of reduction in symptoms.
Review: Knee orthoses for treating patellofemoral pain syndrome
Comparison: 1 Knee orthosis and non-operative intervention (exercises) versus non-operative intervention (exercises) alone
Outcome: 4 Excellent or good results in terms of reduction in symptoms
Study or subgroup
Knee
orthosis +
exercise
Control
(exercise
alone) Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 At 12 weeks
Moller 1986 5/17 7/18 0.76 [ 0.30, 1.93 ]
2 At 12 months
Moller 1986 6/17 7/18 0.91 [ 0.38, 2.16 ]
0.2 0.5 1 2 5
Favours control Favours knee orthosis
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Analysis 1.5. Comparison 1 Knee orthosis and non-operative intervention (exercises) versus non-operative
intervention (exercises) alone, Outcome 5 Functional scores (higher score means higher function).
Review: Knee orthoses for treating patellofemoral pain syndrome
Comparison: 1 Knee orthosis and non-operative intervention (exercises) versus non-operative intervention (exercises) alone
Outcome: 5 Functional scores (higher score means higher function)
Study or subgroup
Knee
orthosis +
exercise
Control
(exercise
alone)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Knee orthosis (any)
Evcik 2010 (1) 41 -11.5 (12) 45 -10.6 (10) 49.8 % -0.08 [ -0.50, 0.34 ]
Lun 2005 (2) 32 38 (8) 17 42 (9) 25.1 % -0.47 [ -1.07, 0.13 ]
Lun 2005 (3) 31 39 (8) 17 42 (9) 25.1 % -0.35 [ -0.95, 0.24 ]
Subtotal (95% CI) 104 79 100.0 % -0.25 [ -0.55, 0.05 ]
Heterogeneity: Chi2 = 1.25, df = 2 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 1.62 (P = 0.10)
2 Sensitivity analysis (knees): Knee orthosis (any)
Evcik 2010 (4) 41 -11.5 (12) 45 -10.6 (10) 40.6 % -0.08 [ -0.50, 0.34 ]
Lun 2005 (5) 45 38 (8) 25 42 (9) 29.6 % -0.47 [ -0.97, 0.02 ]
Lun 2005 (6) 44 39 (8) 25 42 (9) 29.7 % -0.35 [ -0.85, 0.14 ]
Subtotal (95% CI) 130 95 100.0 % -0.28 [ -0.55, -0.01 ]
Heterogeneity: Chi2 = 1.52, df = 2 (P = 0.47); I2 =0.0%
Test for overall effect: Z = 2.02 (P = 0.043)
-1 -0.5 0 0.5 1
Favours control Favours knee orthosis
(1) Knee brace. WOMAC functional score measured at 6 weeks
(2) Knee sleeve: Modified version of the Knee Function Scale at 12 weeks
(3) Knee brace: Modified version of the Knee Function Scale at 12 weeks
(4) Knee brace. WOMAC functional score measured at 6 weeks
(5) Knee sleeve: Modified version of the Knee Function Scale at 12 weeks
(6) Knee brace: Modified version of the Knee Function Scale at 12 weeks
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Analysis 1.6. Comparison 1 Knee orthosis and non-operative intervention (exercises) versus non-operative
intervention (exercises) alone, Outcome 6 Discontinuation of a basic military training programme.
Review: Knee orthoses for treating patellofemoral pain syndrome
Comparison: 1 Knee orthosis and non-operative intervention (exercises) versus non-operative intervention (exercises) alone
Outcome: 6 Discontinuation of a basic military training programme
Study or subgroup
Knee
orthosis +
exercise
Control
(exercise
alone) Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Miller 1997 2/31 0/20 3.28 [ 0.17, 64.99 ]
0.005 0.1 1 10 200
Favours knee orthosis Favours control
Analysis 2.1. Comparison 2 One type of orthosis versus another type, Outcome 1 Pain score (0 to 10:
higher score means worse pain).
Review: Knee orthoses for treating patellofemoral pain syndrome
Comparison: 2 One type of orthosis versus another type
Outcome: 1 Pain score (0 to 10: higher score means worse pain)
Study or subgroup Orthosis 1 Orthosis 2
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Patellar strap versus knee sleeve
Miller 1997 (1) 13 -1.78 (3.04) 18 -2.04 (2.65) 0.26 [ -1.80, 2.32 ]
2 Knee brace versus knee sleeve
Lun 2005 (2) 32 2.7 (2.7) 31 2.8 (2.7) -0.10 [ -1.43, 1.23 ]
3 Knee brace versus knee sleeve (sensitivity analysis: knees)
Lun 2005 (3) 45 2.7 (2.7) 44 2.8 (2.7) -0.10 [ -1.22, 1.02 ]
4 Knee brace versus knee sleeve
Lun 2005 (4) 32 3.2 (2.4) 31 2.5 (2.3) 0.70 [ -0.46, 1.86 ]
5 Knee brace versus knee sleeve (sensitivity analysis: knees)
Lun 2005 (5) 45 3.2 (2.4) 44 2.5 (2.3) 0.70 [ -0.28, 1.68 ]
-2 -1 0 1 2
Favours orthosis 1 Favours orthosis 2
53Knee orthoses for treating patellofemoral pain syndrome (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(1) Change in pain score; pre-treatment to 2 to 3 weeks
(2) Pain during sporting activity at 12 weeks
(3) Pain during sporting activity at 12 weeks
(4) Pain 1 hour after sporting activity at 12 weeks
(5) Pain 1 hour after sporting activity at 12 weeks
Analysis 2.2. Comparison 2 One type of orthosis versus another type, Outcome 2 Functional score (0 to 53:
higher scores means greater function).
Review: Knee orthoses for treating patellofemoral pain syndrome
Comparison: 2 One type of orthosis versus another type
Outcome: 2 Functional score (0 to 53: higher scores means greater function)
Study or subgroup Orthosis 1 Orthosis 2
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Knee brace versus knee sleeve
Lun 2005 (1) 32 38 (8) 31 39 (8) -1.00 [ -4.95, 2.95 ]
2 Knee brace versus knee sleeve (sensitivity analysis: knees)
Lun 2005 (2) 45 38 (8) 44 39 (8) -1.00 [ -4.32, 2.32 ]
-20 -10 0 10 20
Favours knee sleeve Favours knee brace
(1) Modified version of the Knee Function Scale at 12 weeks; unit of analysis issue - inclusion of people with bilateral involvement (44% of population)
(2) Modified version of the Knee Function Scale at 12 weeks; unit of analysis issue - inclusion of people with bilateral involvement (44% of population)
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Analysis 2.3. Comparison 2 One type of orthosis versus another type, Outcome 3 Discontinuation of a basic
military training programme.
Review: Knee orthoses for treating patellofemoral pain syndrome
Comparison: 2 One type of orthosis versus another type
Outcome: 3 Discontinuation of a basic military training programme
Study or subgroup Orthosis 1 Orthosis 2 Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Patellar strap versus knee sleeve
Miller 1997 (1) 0/13 2/18 0.27 [ 0.01, 5.22 ]
0.005 0.1 1 10 200
Favours patellar strap Favours knee sleeve
(1) Continuation of basic military training at 8 weeks after study initiation.
Analysis 2.4. Comparison 2 One type of orthosis versus another type, Outcome 4 Complications.
Review: Knee orthoses for treating patellofemoral pain syndrome
Comparison: 2 One type of orthosis versus another type
Outcome: 4 Complications
Study or subgroup Orthosis 1 Orthosis 2 Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Knee sleeve and patella ring versus knee sleeve without patellar ring
Finestone 1993 (1) 12/22 4/22 3.00 [ 1.14, 7.87 ]
0.02 0.1 1 10 50
Favours sleeve + ring Favours sleeve only
(1) Complications at 14 weeks.
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Analysis 3.1. Comparison 3 Orthosis versus exercise, Outcome 1 Pain during activity (0 to 10: higher score
means worse pain).
Review: Knee orthoses for treating patellofemoral pain syndrome
Comparison: 3 Orthosis versus exercise
Outcome: 1 Pain during activity (0 to 10: higher score means worse pain)
Study or subgroup Knee brace Exercise
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Pain score during sporting activity
Lun 2005 32 2.7 (1.8) 34 2.9 (2.4) -0.20 [ -1.22, 0.82 ]
2 Pain score 1 hour after sporting activity
Lun 2005 32 2.5 (1.8) 34 2.1 (2.2) 0.40 [ -0.57, 1.37 ]
3 Pain score following 30 minutes of sitting with knees flexed
Lun 2005 32 2.9 (2.3) 34 2.5 (2.5) 0.40 [ -0.76, 1.56 ]
-2 -1 0 1 2
Favours knee brace Favours exercise
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Analysis 3.2. Comparison 3 Orthosis versus exercise, Outcome 2 Sensitivity analyses (knees): Pain during
activity (0 to 10: higher score means worse pain).
Review: Knee orthoses for treating patellofemoral pain syndrome
Comparison: 3 Orthosis versus exercise
Outcome: 2 Sensitivity analyses (knees): Pain during activity (0 to 10: higher score means worse pain)
Study or subgroup Knee brace Exercise
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Pain score during sporting activity
Lun 2005 47 2.7 (1.8) 50 2.9 (2.4) -0.20 [ -1.04, 0.64 ]
2 Pain score 1 hour after sporting activity
Lun 2005 47 2.5 (1.8) 50 2.1 (2.2) 0.40 [ -0.40, 1.20 ]
3 Pain score following 30 minutes of sitting with knees flexed
Lun 2005 47 2.9 (2.3) 50 2.5 (2.5) 0.40 [ -0.56, 1.36 ]
-2 -1 0 1 2
Favours knee brace Favours exercise
Analysis 3.3. Comparison 3 Orthosis versus exercise, Outcome 3 Functional scores (0 to 53: higher scores
means greater function).
Review: Knee orthoses for treating patellofemoral pain syndrome
Comparison: 3 Orthosis versus exercise
Outcome: 3 Functional scores (0 to 53: higher scores means greater function)
Study or subgroup Knee brace Exercise
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Participants = denominators
Lun 2005 32 40 (7) 34 42 (9) -2.00 [ -5.88, 1.88 ]
2 Sensitivity analysis (knees)
Lun 2005 47 40 (7) 50 42 (9) -2.00 [ -5.20, 1.20 ]
-20 -10 0 10 20
Favours exercise Favours knee brace
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A P P E N D I C E S
Appendix 1. Search strategies
CENTRAL (Wiley Online Library)
#1 MeSH descriptor: [Patellofemoral Pain Syndrome] this term only (72)
#2 [mh Knee] or [mh ˆ“Knee Injuries”] or [mh ˆ“Knee Joint”] or [mh Patella] (3341)
#3 [mh Ârthralgia] or [mh ˆPain] (10158)
#4 #2 and #3 (365)
#5 “anterior knee pain”:ti,ab,kw (Word variations have been searched) (156)
#6 PFPS:ti,ab,kw (Word variations have been searched) (56)
#7 ((patell* or femoropatell* or femoro-patell* or retropatell* or retro-patell*) near/2 (pain or syndrome or dysfunction or sublux or
malalign* or realign*)):ti,ab,kw (Word variations have been searched) (319)
#8 MeSH descriptor: [Chondromalacia Patellae] this term only (5)
#9 ((chondromalac* or chondropath*) near/2 (knee* or patell* or femoropatell* or femoro-patell* or retropatell* or retro-patell*)):
ti,ab,kw (Word variations have been searched) (32)
#10 ((lateral compression or lateral facet or lateral pressure or odd facet) near syndrome):ti,ab,kw (Word variations have been searched)
(1)
#11 {or #5-#10} (451)
#12 #1 or #4 or #11 (742)
#13 MeSH descriptor: [Rehabilitation] explode all trees (15765)
#14 MeSH descriptor: [Physical Therapy Modalities] explode all trees (16415)
#15 MeSH descriptor: [Physical Therapy Specialty] this term only (114)
#16 MeSH descriptor: [Orthotic Devices] explode all trees (927)
#17 (brace* or sleeve* or strap* or orthotic* or orthosis or orthoses or bandage*):ti,ab,kw (Word variations have been searched)4467
#18 “realign”:ti,ab,kw (Word variations have been searched) (21)
#19 (physiotherapy or physical therapy):ti,ab,kw (Word variations have been searched) (17257)
#20 rehabilitat*:ti,ab,kw (Word variations have been searched) (14093)
#21 Any MeSH descriptor with qualifier(s): [Rehabilitation - RH] (13927)
#22 (non-surg* or nonsurg* or non-operat* or nonoperat* or conserv*):ti,ab,kw (Word variations have been searched) (9270)
#23 {or #13-#22} (61513)
#24 #12 and #23 (319)
MEDLINE (Ovid Online)
1 Patellofemoral Pain Syndrome/ (510)
2 exp Knee/ or Knee Injuries/ or Knee Joint/ or exp Patella/ (65152)
3 Arthralgia/ or Pain/ (116321)
4 2 and 3 (3557)
5 anterior knee pain.tw. (1123)
6 pfps.tw. (297)
7 ((patell$ or femoropatell$ or femoro-patell$ or retropatell$ or retro-patell$) adj2 (pain or syndrome or dysfunction or sublux or
malalign$ or realign$)).tw. (2083)
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8 ((lateral compression or lateral facet or lateral pressure or odd facet) adj syndrome).tw. (21)
9 Chondromalacia Patellae/ (62)
10 ((chondromalac$ or chondropath$) adj2 (knee$1 or patell$ or femoropatell$ or femoro-patell$ or retropatell$ or retro-patell$)).tw.
(512)
11 or/5-10 (3483)
12 1 or 4 or 11 (6408)
13 exp Rehabilitation/ (155245)
14 exp Physical Therapy Modalities/ (129434)
15 Physical Therapy Specialty/ (2236)
16 exp Orthotic Devices/ (9782)
17 (brace$ or sleeve$ or strap$ or orthotic* or orthos#s or bandage$).tw. (22186)
18 realign$.tw. (3331)
19 (physiotherapy or physical therapy).tw. (23363)
20 rehabilitat*.tw. (113902)
21 rh.fs. (169770)
22 (non-surg$ or nonsurg$ or non-operat$ or nonoperat$ or conserv$).tw. (359633)
23 or/13-22 (799951)
24 12 and 23 (1614)
25 Randomized controlled trial.pt. (394854)
26 Controlled clinical trial.pt. (89435)
27 randomized.ab. (320090)
28 placebo.ab. (162328)
29 Drug therapy.fs. (1771045)
30 randomly.ab. (230447)
31 trial.ab. (331205)
32 groups.ab. (1449538)
33 or/25-32 (3528365)
34 exp Animals/ not Humans/ (4037832)
35 33 not 34 (3031597)
36 24 and 35 (452)
EMBASE (Ovid Online)
1 Patellofemoral Pain Syndrome/ (791)
2 Knee/ or Knee Injury/ or Patella/ (59862)
3 Arthralgia/ or Pain/ (255225)
4 2 and 3 (6247)
5 anterior knee pain.tw. (1339)
6 PFPS.tw. (351)
7 ((patell$ or femoropatell$ or femoro-patell$ or retropatell$ or retro-patell$) adj2 (pain or syndrome or dysfunction or sublux or
malalign$ or realign$)).tw. (2424)
8 ((lateral compression or lateral facet or lateral pressure or odd facet) adj syndrome).tw. (25)
9 Patella Chondromalacia/ (597)
10 ((chondromalac$ or chondropath$) adj2 (knee$1 or patell$ or femoropatell$ or femoro-patell$ or retropatell$ or retro-patell$)).tw.
(608)
11 or/5-10 (4280)
12 1 or 4 or 11 (10233)
13 exp Rehabilitation/ (248682)
14 Physiotherapy/ (55685)
15 Orthotics/ (3013)
16 (brace$ or sleeve$ or strap$ or orthotic* or orthos#s or bandage$).tw. (29461)
17 realign$.tw. (3918)
18 (physiotherapy or physical therapy).tw. (33422)
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19 rehabilitat$.tw. (153896)
20 (non-surg$ or nonsurg$ or non-operat$ or nonoperat$ or conserv$).tw. (400593)
21 or/13-20 (811654)
22 12 and 21 (2533)
23 exp Randomized Controlled Trial/ or exp Single Blind Procedure/ or expDouble Blind Procedure/ or Crossover Procedure/ (416387)
24 (random$ or RCT or placebo or allocat$ or crossover$ or ’cross over’ or trial or (doubl$ adj1 blind$) or (singl$ adj1 blind$)).ti,ab.
(1362815)
25 23 or 24 (1438687)
26 (exp Animal/ or animal.hw. or Nonhuman/) not (exp Human/ or Human Cell/ or (human or humans).ti.) (5260646)
27 25 not 26 (1266421)
28 22 and 27 (500)
AMED (Ovid Online)
1 Patellofemoral Pain Syndrome/ (75)
2 Knee/ or Knee Injuries/ or Knee Joint/ or Patella/ (5599)
3 Pain/ or Arthralgia/ (10755)
4 2 and 3 (720)
5 anterior knee pain.tw. (134)
6 PFPS.tw. (115)
7 ((patell$ or femoropatell$ or femoro-patell$ or retropatell$ or retro-patell$) adj2 (pain or syndrome or dysfunction or sublux or
malalign$ or realign$)).tw. (484)
8 ((lateral compression or lateral facet or lateral pressure or odd facet) adj syndrome).tw. (1)
9 ((chondromalac$ or chondropath$) adj2 (knee$1 or patell$ or femoropatell$ or femoro-patell$ or retropatell$ or retro-patell$)).tw.
(27)
10 or/5-9 (603)
11 1 or 4 or 10 (997)
12 Rehabilitation/ (46854)
13 Physical therapy modalities/ (4239)
14 exp Orthotic devices/ (1851)
15 (brace$ or sleeve$ or strap$ or orthotic* or orthos#s or bandage$).tw. (3286)
16 realign$.tw. (129)
17 (physiotherapy or physical therapy).tw. (17720)
18 rehabilitat$.tw. (55498)
19 (non-surg$ or nonsurg$ or non-operat$ or nonoperat$ or conserv$).tw. (2863)
20 or/12-19 (71554)
21 11 and 20 (477)
22 Randomized controlled trial.pt. (3195)
23 Controlled clinical trial.pt. (70)
24 Randomized Controlled Trials/ (1709)
25 Random Allocation/ (312)
26 Double-Blind Method/ (538)
27 or/22-26 (5541)
28 exp Animals/ not Humans/ (8174)
29 27 not 28 (5511)
30 clinical trial.pt. (1167)
31 exp Clinical trials/ (3448)
32 (clinic$ adj25 trial$).tw. (6109)
33 ((singl$ or doubl$ or trebl$ or tripl$) adj (mask$ or blind$)).tw. (2448)
34 Placebos/ (561)
35 placebo$.tw. (2744)
36 random$.tw. (14963)
37 exp Research design/ (18228)
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38 (latin adj square).tw. (24)
39 or/30-38 (32656)
40 39 not 28 (32063)
41 40 not 29 (26708)
42 21 and 41 (99)
CINAHL (EBSCOHost)
S1 (MH “Patellofemoral Pain Syndrome”) (1,005)
S2 (MH “Knee”) OR (MH “Knee Injuries”) OR (MH “Knee Joint”) OR (MH “Patella”) (19,617)
S3 (MH “Arthralgia+”) OR (MH “Pain”) (55,507)
S4 S2 AND S3 (2,193)
S5 TX anterior knee pain (486)
S6 TX PFPS (192)
S7 TX ((patell* or femoropatell* or femoro-patell* or retropatell* or retro-patell*) N2 (pain or syndrome or dysfunction or sublux or
malalign* or realign*)) (1,425)
S8 TX ((lateral compression or lateral facet or lateral pressure or odd facet) N3 syndrome) (8)
S9 (MH “Chondromalacia Patella”) (64)
S10 TX ((chondromalac* or chondropath*) N2 (knee* or patell* or femoropatell* or femoro-patell* or retropatell* or retro-patell*))
(104)
S11 S5 OR S6 OR S7 OR S8 OR S9 OR S10 (1,802)
S12 S1 OR S4 OR S11 (3,308)
S13 (MH “Orthoses+”) (6,903)
S14 TX (brace* or sleeve* or strap* or orthotic* or orthos#s or bandage*) (20,151)
S15 S13 OR S14 (20,393)
S16 S12 AND S15 (343)
S17 PT Clinical Trial (77,889)
S18 (MH “Clinical Trials+”) (187,289)
S19 TI clinical trial* OR AB clinical trial* (45,410)
S20 TI ( (single blind* or double blind*) ) OR AB ( (single blind* or double blind*) ) (21,470)
S21 TI random* OR AB random* (149,549)
S22 S17 OR S18 OR S19 OR S20 OR S21 (277,415)
S23 S16 AND S22 (85)
SPORTDiscus (EBSCOHost)
S1 TX anterior knee pain (595)
S2 TX PFPS (334)
S3 TX ((patell* or femoropatell* or femoro-patell* or retropatell* or retro-patell*) N2 (pain or syndrome or dysfunction or sublux or
malalign* or realign*)) (1,357)
S4 TX ((lateral compression or lateral facet or lateral pressure or odd facet) N2 syndrome) (10)
S5 TX ((chondromalac* or chondropath*) N2 (knee* or patell* or femoropatell* or femoro-patell* or retropatell* or retro-patell*))
(242)
S6 S1 OR S2 OR S3 OR S4 OR S5 (1,926)
S7 DE “ORTHOPEDIC apparatus” (2,529)
S8 TX (brace* or sleeve* or strap* or orthotic* or orthos#s or bandage*) (9,150)
S9 S7 OR S8 (10,112)
S10 S6 AND S9 (195)
S11 TX ( (clinic* N3 trial) or (controlled N3 trial) or (comparative N3 trial) or (placebo N3 trial) or (prospective N3 trial) or (randomi?
ed N3 trial) ) or TX ( (clinic* N3 study) or (controlled N3 study) or (comparative N3 study) or (placebo N3 study) or (prospective
N3 study) or (randomi?ed N3 study) ) (65,289)
S12 (random* N7 allot*) or (random* N7 assign*) or (random* N7 basis*) or (random* N7 divid*) or (random* N7 order*) (8,538)
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S13 TX ( (singl* N7 blind*) or (doubl* N7 blind*) or (trebl* N7 blind*) or (tripl* N7 blind*) ) or TX ( (singl* N7 mask*) or (doubl*
N7 mask*) or (trebl* N7 mask*) or (tripl* N7 mask*) ) (5,465)
S14 TX (cross#over*) or TX (cross N1 over*) (4,067)
S15 TX randomi?ed control* trial* (9,473)
S16 TX ( (allocat* N3 condition*) or (allocat* N3 experiment*) or (allocat* N3 intervention*) or (allocat* N3 treatment*) or (allocat*
N3 therap*) or (allocat* N3 control*) or (allocat* N3 group*) ) or TX ( (allot* N3 condition*) or (allot* N3 experiment*) or (allot*
N3 intervention*) or (allot* N3 treatment*) or (allot* N3 therap*) or (allot* N3 control*) or (allot* N3 group*) ) or TX ( (assign* N3
condition*) or (assign* N3 experiment*) or (assign* N3 intervention*) or (assign* N3 treatment*) or (assign* N3 therap*) or (assign*
N3 control*) or (assign* N3 group*) ) or TX ( (divid* N3 condition*) or (divid* N3 experiment*) or (divid* N3 intervention*) or
(divid* N3 treatment*) or (divid* N3 therap*) or (divid* N3 control*) or (divid* N3 group*) ) (9,275)
S17 TX placebo* (7,914)
S18 S11 or S12 or S13 or S14 or S15 or S16 or S17 (80,389)
S19 S10 AND S18 (63)
Physiotherapy Evidence Databases (PEDro Platform)
a) Simple Search
1. Patella* and brac* (31)
2. Patella* and strap (4)
3. Patella* and ortho* (128)
4. Patella* and sleeve (2)
5. Patella* and bandage (1)
6. Knee and brac* (161)
7. Knee and ortho* (1224)
8. Knee and strap (5)
9. Knee and sleeve (13)
10. Knee and bandage (65)
b) Advanced Search
Abstract and title: patell
Therapy: orthoses, taping, splinting
Body Part: lower leg or knee
Method: clinical trial
Total = 48
WHO International Clinical Trials Registry Platform
1. Patell* and brac* (9)
2. Patell* and strap* (5)
3. Patell* and orthos* (9)
4. Patell* and orthot* (3)
5. Patell* and sleeve* (0)
6. Patell* and bandag* (4)
7. Knee and brac* (41)
8. Knee and strap* (16)
9. Knee and orthos* (28)
10. Knee and orthot* (21)
11. Knee and sleeve* (3)
12. Knee and bandag* (20)
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Current Controlled Trials
1. Knee and brace (12)
2. Knee and strap (4)
3. Knee and orthosis (8)
4. Knee and orthotic (6)
5. Knee and sleeve (1)
6. Knee and bandage (10)
7. Knee and ortho* (1)
8. Knee and brac* (0)
9. Patell* and ortho* (0)
10. Patell* and brac* (0)
OpenGrey
1. Knee brac* (5)
2. Knee strap (0)
3. Knee ortho* (51)
4. Knee sleeve (0)
5. Knee bandage (0)
6. Patell* brac* (1)
7. Patell* ortho* (11)
8. Patell* strap (0)
9. Patell* sleeve (0)
10. Patell* bandage (0)
Orthopaedic Proceedings (Bone and Joint Journal Website)
1. Patello* and random* (48)
2. Anterior knee pain and random* (80)
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
There were insufficient data to perform subgroup analyses of custom-made orthosis to a pre-fabricated (off-the-shelf ) version, of people
age 18 years or over versus those aged under 18 years, or the level of activity (participants who were professional athletes or in the
military forces versus recreational athletes).
Wemerged two original comparators into one comparator on data analysis. The protocol stipulated the comparators ’knee orthosis versus
no treatment’ and ’knee orthosis and non-operative intervention (e.g. exercise) versus non-operative intervention alone’. On reflection
of the results from the included studies, these appeared arbitrary distinctions where all participants received some form of treatment, be
that exercise or basic military training, which would include knee exercises. Therefore we synthesised these two comparators into the
single ’knee orthosis and non-operative intervention (e.g. exercise) versus non-operative intervention alone’ comparator as presented in
the review.
Due to the available data, it was not possible to present an informative ’Summary of Findings’ table for all planned comparisons.
Therefore we only presented a ’Summary of Findings’ table for the main comparison (Knee orthosis and non-operative intervention
(e.g. exercise) versus non-operative intervention alone).
It was not possible to perform a sensitivity analysis of the presentation of 90% of data versus greater than 10% lost to follow-up data
due to insufficient data for such an analysis.
It was not possible to investigate outcomes dependent on the mode of knee orthoses such as length of time worn per day, whether the
orthosis was worn only during physical activity, during therapeutic exercises or all day, since this had not been specifically investigated
within the available literature for specific forms of knee orthoses.
It was not possible to assess publication bias for such small sample sizes: the largest number of trials pooled in this review was three.
Consequently, it was not possible to ascertain whether the findings of this review were, or were not, affected by publication bias.
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